[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 22944
1. Blick C, Abdelhadi S, Bailey D, Muneer A: Anaplastic, T-cell, non-Hodgkin's Lymphoma presenting with haematuria. ScientificWorldJournal; 2008;8:342-5
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anaplastic, T-cell, non-Hodgkin's Lymphoma presenting with haematuria.
  • Non-Hodgkin's lymphoma (NHL) represents about 3% of new cancer cases[1].
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18379710.001).
  • [ISSN] 1537-744X
  • [Journal-full-title] TheScientificWorldJournal
  • [ISO-abbreviation] ScientificWorldJournal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


2. Chari S, Haines T, Varghese P, Economidis A: Are non-slip socks really 'non-slip'? An analysis of slip resistance. BMC Geriatr; 2009;9:39

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Are non-slip socks really 'non-slip'? An analysis of slip resistance.
  • BACKGROUND: Non-slip socks have been suggested as a means of preventing accidental falls due to slips.
  • This study compared the relative slip resistance of commercially available non-slip socks with other foot conditions, namely bare feet, compression stockings and conventional socks, in order to determine any traction benefit.
  • METHODS: Phase one involved slip resistance testing of two commercially available non-slip socks and one compression-stocking sample through an independent blinded materials testing laboratory using a Wet Pendulum Test.Phase two of the study involved in-situ testing among healthy adult subjects (n = 3).
  • Subjects stood unsupported on a variable angle, inclined platform topped with hospital grade vinyl, in a range of foot conditions (bare feet, non-slip socks, conventional socks and compression stockings).
  • RESULTS: Phase one results generated through Wet Pendulum Test suggested that non-slip socks did not offer better traction than compression stockings.
  • CONCLUSION: It is evident that bare feet provide better slip resistance than non-slip socks and therefore might represent a safer foot condition.
  • [MeSH-minor] Accidental Falls / prevention & control. Adult. Equipment Design / standards. Female. Foot. Friction. Humans. Male. Protective Clothing / standards. Stockings, Compression / standards. Surface Properties

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Age Ageing. 2003 May;32(3):310-4 [12720618.001]
  • [Cites] BMJ. 2004 Mar 20;328(7441):676 [15031238.001]
  • [Cites] Age Ageing. 2004 Jul;33(4):390-5 [15151914.001]
  • [Cites] J Am Geriatr Soc. 2004 Sep;52(9):1495-501 [15341551.001]
  • [Cites] Osteoporos Int. 2007 Feb;18(2):167-75 [17061151.001]
  • [Cites] Gerontology. 2005 Sep-Oct;51(5):329-33 [16110235.001]
  • [Cites] Med J Aust. 2006 Apr 17;184(8):379-82 [16618235.001]
  • [Cites] Gerontology. 2006;52(3):174-80 [16645298.001]
  • [Cites] Geriatr Nurs. 1996 Jan-Feb;17(1):24-6 [8707140.001]
  • (PMID = 19706167.001).
  • [ISSN] 1471-2318
  • [Journal-full-title] BMC geriatrics
  • [ISO-abbreviation] BMC Geriatr
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2752454
  •  go-up   go-down


3. Soulier J, Clappier E, Cayuela JM, Regnault A, García-Peydró M, Dombret H, Baruchel A, Toribio ML, Sigaux F: HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood; 2005 Jul 1;106(1):274-86
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL).
  • Using a combination of molecular cytogenetic and large-scale expression analysis in human T-cell acute lymphoblastic leukemias (T-ALLs), we identified and characterized a new recurrent chromosomal translocation, targeting the major homeobox gene cluster HOXA and the TCRB locus.
  • [MeSH-major] Gene Expression Regulation, Leukemic. Homeodomain Proteins / genetics. Leukemia-Lymphoma, Adult T-Cell / genetics. Translocation, Genetic
  • [MeSH-minor] Adolescent. Adult. Aged. Cell Differentiation / genetics. Child. Child, Preschool. Female. Gene Expression Profiling. Humans. Infant. Male. Middle Aged. Multigene Family. T-Lymphocytes / cytology. T-Lymphocytes / physiology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15774621.001).
  • [ISSN] 0006-4971
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Homeodomain Proteins; 157907-48-7 / HoxA protein
  •  go-up   go-down


Advertisement
4. Chiseliţă D, Moţoc I, Danielescu C: [Concordance of nictemeral IOP variations between fellow eyes in glaucoma and non glaucoma patients]. Oftalmologia; 2008;52(3):102-9
Genetic Alliance. consumer health - Glaucoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Concordance of nictemeral IOP variations between fellow eyes in glaucoma and non glaucoma patients].
  • [Transliterated title] Concordanţa fluctuaţiilor nictemerale ale presiunii intraoculare între ochii congeneri la pacienţi glaucomatoşi şi non-glaucomatoşi.
  • PURPOSE: To study the concordance of nictemeral IOP variations between fellow eyes in patients with treated and untreated OHT/POAG versus non-glaucoma patients.
  • The patients were classified: group 1--36 non-glaucoma patients (control group), group 2--32 patients with OHT and POAG without treatment, group 3--43 patients with OHT and POAG with a satisfactory diurnal therapeutic control of IOP (daytime IOP>21 mmHg) and group 4--13 patients with POAG with unsatisfactory control of IOP under maximal tolerated medication (daytime IOP>21 mmHg).
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Algorithms. Analysis of Variance. Cross-Sectional Studies. Female. Humans. Male. Middle Aged. Reference Values. Risk Factors. Tonometry, Ocular / methods. Visual Fields

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19149128.001).
  • [ISSN] 1220-0875
  • [Journal-full-title] Oftalmologia (Bucharest, Romania : 1990)
  • [ISO-abbreviation] Oftalmologia
  • [Language] rum
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


5. Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K, Reman O, Witz F, Fagot T, Tavernier E, Turlure P, Leguay T, Huguet F, Vernant JP, Daniel F, Béné MC, Ifrah N, Thomas X, Dombret H, Macintyre E: NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood; 2009 Apr 23;113(17):3918-24
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
  • Many somatic genetic abnormalities have been identified in T-cell acute lymphoblastic leukemia (T-ALL) but each individual abnormality accounts for a small proportion of cases; therapeutic stratification consequently still relies on classical clinical markers.
  • We screened 141 adult diagnostic T-ALL samples from patients treated on either the Lymphoblastic Acute Leukemia in Adults (LALA)-94 (n = 87) or the GRAALL-2003 (n = 54) trials.
  • [MeSH-major] Cell Cycle Proteins / genetics. F-Box Proteins / genetics. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / classification. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics. Receptor, Notch1 / genetics. Ubiquitin-Protein Ligases / genetics
  • [MeSH-minor] Adult. Genotype. Humans. Mutation / genetics. Phenotype. Prognosis. Societies, Medical. Survival Rate. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19109228.001).
  • [ISSN] 1528-0020
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / F-Box Proteins; 0 / Receptor, Notch1; EC 6.3.2.19 / FBXW7 protein, human; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


6. Burmeister T, Gökbuget N, Reinhardt R, Rieder H, Hoelzer D, Schwartz S: NUP214-ABL1 in adult T-ALL: the GMALL study group experience. Blood; 2006 Nov 15;108(10):3556-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] NUP214-ABL1 in adult T-ALL: the GMALL study group experience.
  • The NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia (T-ALL) has recently been identified as a possible target for imatinib and related tyrosine kinase inhibitors, but exact data regarding the prognostic impact and frequency of the several putative NUP214-ABL1 mRNA transcripts are still missing.
  • We investigated 279 adult patients with T-ALL treated within the framework of the GMALL 5/93 and 6/99 therapy trials for NUP214-ABL1 by using a novel multiplex real-time, quantitative polymerase chain reaction (PCR).
  • [MeSH-major] Leukemia-Lymphoma, Adult T-Cell / genetics. Nuclear Pore Complex Proteins / genetics. Oncogene Proteins, Fusion / genetics. Proto-Oncogene Proteins c-abl / genetics
  • [MeSH-minor] Adolescent. Adult. Benzamides. Female. Humans. Imatinib Mesylate. Immunophenotyping. Male. Piperazines / therapeutic use. Polymerase Chain Reaction. Prognosis. Protein-Tyrosine Kinases / antagonists & inhibitors. Pyrimidines / therapeutic use. RNA, Messenger / analysis. Survival Rate

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. IMATINIB MESYLATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16873673.001).
  • [ISSN] 0006-4971
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Benzamides; 0 / NUP214 protein, human; 0 / Nuclear Pore Complex Proteins; 0 / Oncogene Proteins, Fusion; 0 / Piperazines; 0 / Pyrimidines; 0 / RNA, Messenger; 8A1O1M485B / Imatinib Mesylate; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.2 / Proto-Oncogene Proteins c-abl
  •  go-up   go-down


7. Kadan-Lottick NS, Zeltzer LK, Liu Q, Yasui Y, Ellenberg L, Gioia G, Robison LL, Krull KR: Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers. J Natl Cancer Inst; 2010 Jun 16;102(12):881-93
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers.
  • BACKGROUND We sought to measure self-reported neurocognitive functioning among survivors of non-central nervous system (CNS) childhood cancers, overall and compared with a sibling cohort, and to identify factors associated with worse functioning.
  • METHODS In a retrospective cohort study, 5937 adult survivors of non-CNS cancers and 382 siblings completed a validated neuropsychological instrument with subscales in task efficiency, emotional regulation, organization, and memory.
  • Non-CNS cancer survivors and siblings were compared with multivariable linear regression and log-binomial regression.
  • RESULTS Non-CNS cancer survivors had similar or slightly worse (<0.5 standard deviation) mean test scores for all four subscales than siblings.
  • Impaired task efficiency was most often identified in patients with acute lymphoblastic leukemia who received cranial radiation therapy (18.1% with impairment), myeloid leukemia who received cranial radiation therapy (21.2%), and non-Hodgkin lymphoma (13.9%).
  • CONCLUSION A statistically and clinically significantly higher percentage of self-reported neurocognitive impairment was found among survivors of non-CNS cancers than among siblings.

  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • MedlinePlus Health Information. consumer health - Cancer--Living with Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2001 Apr 19;344(16):1207-13 [11309635.001]
  • [Cites] Psychosomatics. 2001 May-Jun;42(3):241-6 [11351113.001]
  • [Cites] Neurology. 2001 Jun 12;56(11):1539-45 [11402112.001]
  • [Cites] Child Neuropsychol. 2000 Sep;6(3):235-8 [11419452.001]
  • [Cites] Med Pediatr Oncol. 2002 Apr;38(4):229-39 [11920786.001]
  • [Cites] J Pediatr Hematol Oncol. 2002 Feb;24(2):106-14 [11990695.001]
  • [Cites] Med Pediatr Oncol. 2002 May;38(5):320-8 [11979456.001]
  • [Cites] Pediatrics. 2002 Jul;110(1 Pt 1):42-52 [12093945.001]
  • [Cites] Eur J Cancer. 2003 Feb;39(3):359-65 [12565989.001]
  • [Cites] Cancer. 2003 Feb 15;97(4):1115-26 [12569614.001]
  • [Cites] Lancet Oncol. 2004 Jul;5(7):399-408 [15231246.001]
  • [Cites] Lancet. 1981 Nov 7;2(8254):1015-8 [6118478.001]
  • [Cites] Pediatrics. 1985 Apr;75(4):745-53 [3838584.001]
  • [Cites] Biometrics. 1986 Mar;42(1):121-30 [3719049.001]
  • [Cites] J Clin Oncol. 1988 Feb;6(2):315-20 [3422262.001]
  • [Cites] J Child Psychol Psychiatry. 1988 Nov;29(6):839-52 [3069852.001]
  • [Cites] Am J Pediatr Hematol Oncol. 1989 Spring;11(1):74-86 [2496615.001]
  • [Cites] Dev Med Child Neurol. 1990 Mar;32(3):238-48 [2311827.001]
  • [Cites] J Clin Oncol. 1991 Jan;9(1):145-51 [1985164.001]
  • [Cites] J Clin Oncol. 1991 Aug;9(8):1348-56 [2072138.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1992;22(1):13-6 [1727109.001]
  • [Cites] J Pediatr. 1992 Dec;121(6):885-9 [1447650.001]
  • [Cites] Lancet. 1994 Jul 23;344(8917):224-7 [7913156.001]
  • [Cites] J Clin Oncol. 1998 May;16(5):1712-22 [9586883.001]
  • [Cites] J Pediatr Psychol. 1998 Oct;23(5):333-40 [9782681.001]
  • [Cites] J Pediatr Psychol. 2005 Jan-Feb;30(1):65-78 [15610986.001]
  • [Cites] Pediatr Blood Cancer. 2005 Sep;45(3):281-90 [15806539.001]
  • [Cites] J Pediatr Hematol Oncol. 2000 May-Jun;22(3):206-13 [10864051.001]
  • [Cites] J Clin Oncol. 2006 Aug 20;24(24):3858-64 [16921038.001]
  • [Cites] J Natl Cancer Inst. 2006 Dec 6;98(23):1742-5 [17148777.001]
  • [Cites] J Clin Oncol. 2007 Nov 1;25(31):4914-21 [17971588.001]
  • [Cites] Pediatrics. 2007 Nov;120(5):e1229-36 [17974716.001]
  • [Cites] Neuropsychol Rev. 2008 Jun;18(2):121-31 [18415683.001]
  • [Cites] J Clin Oncol. 2008 Jun 20;26(18):3025-30 [18565888.001]
  • [Cites] Cancer. 2008 Oct 15;113(8):2188-97 [18792068.001]
  • [Cites] Pediatr Blood Cancer. 2009 Feb;52(2):159-64 [18680151.001]
  • [Cites] J Int Neuropsychol Soc. 2009 Jan;15(1):31-41 [19128526.001]
  • [Cites] J Clin Oncol. 2009 May 10;27(14):2308-18 [19364948.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2626-35 [19815636.001]
  • [Cites] Neuropsychology. 2009 Nov;23(6):705-17 [19899829.001]
  • [Cites] Eur J Pharmacol. 2010 Jan 10;626(1):83-6 [19835870.001]
  • [CommentIn] J Natl Cancer Inst. 2011 Apr 6;103(7):607; author reply 607-9 [21350219.001]
  • (PMID = 20458059.001).
  • [ISSN] 1460-2105
  • [Journal-full-title] Journal of the National Cancer Institute
  • [ISO-abbreviation] J. Natl. Cancer Inst.
  • [Language] ENG
  • [Grant] United States / NCRR NIH HHS / RR / KL2 RR024138; United States / NCI NIH HHS / CA / U24-CA55727
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2886093
  •  go-up   go-down


8. Ehui E, Tanon A, Guié P, Aba T, Toa-Lou C, Kassi A, Ouattara I, Kouakou G, Mossou C, Kakou A, Eholié S, Aoussi E, Bissagnéné E: [Antiretroviral prophylaxis after non-occupational exposure to HIV in Abidjan (Cote d'Ivoire)]. Med Mal Infect; 2010 Oct;40(10):574-81
HIV InSite. treatment guidelines - Adherence to HIV Antiretroviral Therapy .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Antiretroviral prophylaxis after non-occupational exposure to HIV in Abidjan (Cote d'Ivoire)].
  • [Transliterated title] Prophylaxie antirétrovirale après expositions non professionnelles au VIH à Abidjan (Cote d'Ivoire).
  • OBJECTIVE: The aim of this study was to assess the tolerability and adherence to all non-occupational post-exposure prophylaxis (PEP) for cases of HIV exposure in Abidjan.
  • METHOD: We retrospectively studied all post-exposure prophylaxis for non-occupational exposures to HIV prescribed from January 1st, 2000 to December 31st, 2007 in the Abidjan infectious diseases department.
  • RESULTS: Over these eight years, we managed 128 consultations for non-professional exposures to HIV (50 male [39%], 78 female patients [61%]), average age 24.8 years (four-54 years).
  • [MeSH-minor] Adolescent. Adult. Bites, Human. Child. Child, Preschool. Condoms. Cote d'Ivoire. Equipment Failure. Female. Gastrointestinal Diseases / chemically induced. HIV Protease Inhibitors / administration & dosage. HIV Protease Inhibitors / adverse effects. HIV Protease Inhibitors / therapeutic use. HIV Seropositivity. Humans. Male. Middle Aged. Needlestick Injuries. Patient Compliance. Rape. Retrospective Studies. Treatment Outcome. Unsafe Sex. Young Adult

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • MedlinePlus Health Information. consumer health - HIV/AIDS Medicines.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 20554137.001).
  • [ISSN] 1769-6690
  • [Journal-full-title] Médecine et maladies infectieuses
  • [ISO-abbreviation] Med Mal Infect
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Anti-HIV Agents; 0 / HIV Protease Inhibitors
  •  go-up   go-down


9. Fekecs T, Kádár Z, Battyáni Z, Kalmár-Nagy K, Szakály P, Wéber G, Horváth OP, Ferencz A: [Clinical study of non-melanoma skin cancer following human organ transplantation]. Magy Seb; 2010 Apr;63(2):84-90
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical study of non-melanoma skin cancer following human organ transplantation].
  • [Transliterated title] A szervtranszplantációt követo non-melanoma bortumorok klinikai vizsgálata.
  • INTRODUCTION: Increasing evidence suggests that non-melanoma skin cancers (NMSC) are the most frequent tumours in transplanted patients.
  • PATIENTS AND METHODS: 116 adult, "Caucasian" (white skin) transplanted (kidney, simultaneous-pancreas-kidney) patients (70 male and 46 female) of the Surgical Department of Pécs University were enrolled from September 2008.


10. Mascaux C, Iannino N, Berghmans T, Meert AP, Sculier JP: [Docetaxel as salvage treatment for non-small cell lung cancer: implementation study]. Rev Med Brux; 2005 May-Jun;26(3):153-8
Hazardous Substances Data Bank. DOCETAXEL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Docetaxel as salvage treatment for non-small cell lung cancer: implementation study].
  • [Transliterated title] Le docétaxel comme traitement de rattrapage pour les cancers bronchiques non à petites cellules: étude d'implementation.
  • Salvage treatment with docetaxel after failure of cisplatin-based chemotherapy in non-small cell lung cancer (NSCLC) has already been tested in the context of clinical prospective trials but only dealing with selected patients.
  • [MeSH-major] Antineoplastic Agents, Phytogenic / therapeutic use. Carcinoma, Non-Small-Cell Lung / drug therapy. Lung Neoplasms / drug therapy. Taxoids / therapeutic use
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Retrospective Studies. Salvage Therapy

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16038139.001).
  • [ISSN] 0035-3639
  • [Journal-full-title] Revue médicale de Bruxelles
  • [ISO-abbreviation] Rev Med Brux
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Belgium
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Taxoids; 15H5577CQD / docetaxel
  • [Number-of-references] 15
  •  go-up   go-down


11. Revest M, Decaux O, Frouget T, Cazalets C, Albert JD, Chevrier S, Guiguen C, Jego P, Grosbois B: [Cryptococcal infections in non-HIV infected patients. Study of four cases and review of literature]. Rev Med Interne; 2006 Mar;27(3):203-8
HIV InSite. treatment guidelines - Cardiac Cardiac Manifestations of HIV .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cryptococcal infections in non-HIV infected patients. Study of four cases and review of literature].
  • [Transliterated title] Infections à cryptocoque chez des patients non VIH. A propos de quatre cas et revue de la littérature.
  • METHODS: We report four cases of cryptococcal infections in patients whose immunosuppression isn't related with HIV infection but due to chronic lymphocytic leukemia, giant cell temporal arteritis, gastric neoplasm and lupus.
  • CONCLUSION: Cryptococcal infection may occur in patients non-HIV-infected patients.

  • Genetic Alliance. consumer health - HIV.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16364503.001).
  • [ISSN] 0248-8663
  • [Journal-full-title] La Revue de medecine interne
  • [ISO-abbreviation] Rev Med Interne
  • [Language] FRE
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 26
  •  go-up   go-down


12. Gauthier T, Fermeaux V, Mollard J, Aubard Y: [Low invasion in sentinel lymph node according to the European Working Group In Breast Screening Pathology (EWGBSP) recommendations and non sentinel invasion risk in breast cancer]. Gynecol Obstet Fertil; 2009 Jun;37(6):481-7
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Low invasion in sentinel lymph node according to the European Working Group In Breast Screening Pathology (EWGBSP) recommendations and non sentinel invasion risk in breast cancer].
  • [Transliterated title] Atteinte minime du ganglion sentinelle selon les recommandations de l'European Working Group in Breast Screening Pathology (EWGBSP) et risque d'atteinte non sentinelle dans le cancer du sein.
  • OBJECTIVE: Because of variability in histopathological interpretations in studies, it's difficult to elucidate the risk of non-sentinel lymph node involvement in case of sentinel node nanometastases (lesions not larger than 0.2 mm) and micrometastases (lesions not larger than 2 mm but larger than 0.2 mm) in breast cancer.
  • The percentage of pN1mi patients who had non sentinel involvement is 8.89%.
  • None of pN0i+ patients had non sentinel involvement.
  • Any non sentinel involvement was detected in case of sentinel lymph node nanometastases.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Axilla. Female. Humans. Lymph Node Excision / methods. Lymph Nodes / pathology. Lymph Nodes / surgery. Middle Aged. Neoplasm Invasiveness. Neoplasm Metastasis. Practice Guidelines as Topic. Risk Assessment. Risk Factors. Sentinel Lymph Node Biopsy

  • Genetic Alliance. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19457697.001).
  • [ISSN] 1297-9589
  • [Journal-full-title] Gynécologie, obstétrique & fertilité
  • [ISO-abbreviation] Gynecol Obstet Fertil
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


13. Kalayci R, Altindiş M, Gülamber G, Demirtürk N, Akcan Y, Demirdal T: [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases]. Mikrobiyol Bul; 2010 Apr;44(2):237-43
Hazardous Substances Data Bank. LAMIVUDINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mutational analysis and antiviral drug resistance studies were performed by sequence analysis (ABI PRISM 310 Genetic Analyzer; Applied Biosystems, USA), with the use of the region between 80-260 codons in HBV DNA polymerase gene, and the genotype determining sequences in 5' non-coding region in HCV genome.
  • [MeSH-minor] Adenine / analogs & derivatives. Adenine / pharmacology. Adolescent. Adult. Aged. Antiviral Agents / pharmacology. Antiviral Agents / therapeutic use. DNA Mutational Analysis. DNA, Viral / chemistry. DNA-Directed DNA Polymerase / genetics. Drug Resistance, Viral / genetics. Female. Genotype. Humans. Lamivudine / pharmacology. Lamivudine / therapeutic use. Male. Middle Aged. Mutation. Organophosphonates / pharmacology. Young Adult

  • Genetic Alliance. consumer health - Hepatitis.
  • Hazardous Substances Data Bank. Adefovir .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20549958.001).
  • [ISSN] 0374-9096
  • [Journal-full-title] Mikrobiyoloji bülteni
  • [ISO-abbreviation] Mikrobiyol Bul
  • [Language] tur
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Turkey
  • [Chemical-registry-number] 0 / Antiviral Agents; 0 / DNA, Viral; 0 / Organophosphonates; 2T8Q726O95 / Lamivudine; 6GQP90I798 / adefovir; EC 2.7.7.7 / DNA-Directed DNA Polymerase; JAC85A2161 / Adenine
  •  go-up   go-down


14. Wieczorek M, Hoeltgen R, Djajadisastra I: [Avoidance of intermittent T-wave oversensing with device programming]. Herzschrittmacherther Elektrophysiol; 2006 Jun;17(2):106-11
MedlinePlus Health Information. consumer health - Pacemakers and Implantable Defibrillators.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • He underwent heart transplantation years ago and developed complex ventricular arrhythmias in the following months in combination with recurrent episodes of syncope due to hypertrophic non-obstructive cardiomyopathy in the transplanted heart, so a dual chamber ICD was implanted.
  • [MeSH-minor] Adult. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pacing Clin Electrophysiol. 2001 Nov;24(11):1701-3 [11816645.001]
  • [Cites] Pacing Clin Electrophysiol. 1996 May;19(5):863-7 [8734757.001]
  • [Cites] Pacing Clin Electrophysiol. 2004 May;27(5):681-3 [15125731.001]
  • [Cites] J Cardiovasc Electrophysiol. 2003 Dec;14(12):1273-7 [14678099.001]
  • [Cites] Europace. 2001 Jan;3(1):80-4 [11271957.001]
  • [Cites] Jpn Circ J. 2001 Jul;65(7):685-7 [11446507.001]
  • [Cites] Pacing Clin Electrophysiol. 1998 Jul;21(7):1490-1 [9670199.001]
  • [Cites] Pacing Clin Electrophysiol. 2003 Jan;26(1 Pt 1):65-70 [12685142.001]
  • (PMID = 16786469.001).
  • [ISSN] 0938-7412
  • [Journal-full-title] Herzschrittmachertherapie & Elektrophysiologie
  • [ISO-abbreviation] Herzschrittmacherther Elektrophysiol
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


15. Faurie P, Pérard L, Hot A, Desmurs-Clavel H, Fassier T, Boibieux A, Ninet J: [Recurrent aseptic meningitis secondary to nonsteroidal anti-inflammatory drugs in a patient with lupus]. Rev Med Interne; 2010 Oct;31(10):e1-3
Hazardous Substances Data Bank. IBUPROFEN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Méningite aseptique récidivante due aux anti-inflammatoires non stéroïdiens chez une patiente lupique.
  • She presented two episodes following ibuprofen administration that were characterized by aseptic meningitis with high protein level in cerebrospinal fluid, and increased serum acute phase reactants.

  • Genetic Alliance. consumer health - Lupus.
  • MedlinePlus Health Information. consumer health - Lupus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.
  • (PMID = 20541295.001).
  • [ISSN] 1768-3122
  • [Journal-full-title] La Revue de medecine interne
  • [ISO-abbreviation] Rev Med Interne
  • [Language] FRE
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; WK2XYI10QM / Ibuprofen
  •  go-up   go-down


16. Ferron G, Aziza R, Delannes M, Filleron T, Marquès B, Labarre D, Labarre D, Chevreau C: Detection of local recurrences of limb soft-tissue sarcomas: Is magnetic resonance imaging (MRI) relevant? J Clin Oncol; 2009 May 20;27(15_suppl):10582

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of our study was to retrospectively evaluate the effectiveness of a MRI surveillance schedule performed in adult patients.
  • METHODS: 124 adult patients have been treated from 1996 to 2006 for a non-metastatic limb STS at our centre: 86 patients (70%) had clear resection margins (R0) and 111 patients (90%) received an adjuvant radiotherapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963876.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Goldman S, Coiffier B, Reiter A, Younes A, Cairo MS, International TLS Expert Panel: A medical decision tree for the prophylaxis (P) and treatment (T) of tumor lysis syndrome (TLS): An international TLS consensus panel. J Clin Oncol; 2009 May 20;27(15_suppl):e17575

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We convened an international panel (N = 17) of experts in pediatric and adult hematological malignancies and solid tumors (ST) to develop a medical decision tree for the P and T of TLS based on the risk classification (low, medium, high) and management recommendations of Coiffier et al (J Clin Oncol.
  • MRD consisted of ALL ≤100K/mm<sup>3</sup>, AML 25-100K/mm<sup>3</sup>, BL/LL stage I/II and low LDH, childhood ALCL, DLBCL/PTCL/MCL/ATL non-bulky but elevated LDH, CLL treated with targeted therapy, and LRD with renal impairment/involvement.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963935.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Cortes JE, Khoury HJ, Corm S, Nicolini F, Schenk T, Jones D, Hochhaus A, Craig AR, Humphriss E, Kantarjian H, Omacetaxine 202 Study Group: Subcutaneous omacetaxine mepesuccinate in imatinib-resistant chronic myeloid leukemia (CML) patients (Pts) with the T315I mutation: Data from an ongoing phase II/III trial. J Clin Oncol; 2009 May 20;27(15_suppl):7008

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Subcutaneous omacetaxine mepesuccinate in imatinib-resistant chronic myeloid leukemia (CML) patients (Pts) with the T315I mutation: Data from an ongoing phase II/III trial.
  • METHODS: Adult Pts with T315I+ CML following TKI failure received OM induction at 1.25 mg/m<sup>2</sup> subcutaneous (SC) twice daily (BID) for 14 days every 28 days followed by maintenance at 1.25 mg/m<sup>2</sup> SC BID for 7 days every 28 days (maintenance after at least one induction cycle and achievement of hematologic response).
  • Grade 3/4 non-hematologic events are diarrhea (2%) and fatigue (4%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961380.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Turculeţ C, Popa B, Palea M, Venter D, Feodor T, Dinescu G: [Non-surgical management of patients with blunt abdominal injury: the role of angiography]. Chirurgia (Bucur); 2008 Jan-Feb;103(1):79-85

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Non-surgical management of patients with blunt abdominal injury: the role of angiography].
  • [Transliterated title] Aspecte ale tratamentului non-operator al traumatismelor abdominale închise: rolul angiografiei.
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Kidney / injuries. Liver / injuries. Male. Middle Aged. Sensitivity and Specificity. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18459502.001).
  • [ISSN] 1221-9118
  • [Journal-full-title] Chirurgia (Bucharest, Romania : 1990)
  • [ISO-abbreviation] Chirurgia (Bucur)
  • [Language] rum
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


20. Pamukçuoğlu M, Nasiroğlu N, Yildirim N, Ozçelik O, Oksüzoğlu B, Abali H, Zengin N: [Sinonasal NK/T-cell lymphoma mimicking Wegener's granulomatosis: a case report]. Tuberk Toraks; 2006;54(3):277-80
MedlinePlus Health Information. consumer health - Granulomatosis with Polyangiitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In Western population, sinonasal malignant lymphoma is rare and constitutes 1.5% of all non-Hodgkin lymphoma (NHL) and 2.2% of extranodal lymphomas.
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans

  • Genetic Alliance. consumer health - Wegener's granulomatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17001547.001).
  • [ISSN] 0494-1373
  • [Journal-full-title] Tüberküloz ve toraks
  • [ISO-abbreviation] Tuberk Toraks
  • [Language] tur
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


21. Obrtlíková P, Pytlík R, Hofman P, Cervinková P: [Flow cytometric differential gating strategy for evaluation of T-lymphocyte survival and proliferation in mixed lymphocyte reaction with dendritic cells]. Epidemiol Mikrobiol Imunol; 2005 Aug;54(3):109-15
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Differential gating distinguishes populations of all living cells (R1), living non-proliferating cells (R2) and dead/apoptotic cells (R4).
  • [MeSH-minor] Adult. Aged. Antigens, CD / analysis. Dendritic Cells. Female. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16173521.001).
  • [ISSN] 1210-7913
  • [Journal-full-title] Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceské lékarské spolecnosti J.E. Purkyne
  • [ISO-abbreviation] Epidemiol Mikrobiol Imunol
  • [Language] cze
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Czech Republic
  • [Chemical-registry-number] 0 / Antigens, CD
  •  go-up   go-down


22. Van Vlierberghe P, Homminga I, Zuurbier L, Gladdines-Buijs J, van Wering ER, Horstmann M, Beverloo HB, Pieters R, Meijerink JP: Cooperative genetic defects in TLX3 rearranged pediatric T-ALL. Leukemia; 2008 Apr;22(4):762-70
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive neoplastic disorder, in which multiple genetic abnormalities cooperate in the malignant transformation of thymocytes.
  • [MeSH-major] Chromosome Aberrations. Homeodomain Proteins / genetics. Leukemia-Lymphoma, Adult T-Cell / genetics. Sequence Deletion

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18185524.001).
  • [ISSN] 1476-5551
  • [Journal-full-title] Leukemia
  • [ISO-abbreviation] Leukemia
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / F-Box Proteins; 0 / Homeodomain Proteins; 0 / TLX3 protein, human; 0 / WT1 Proteins; EC 6.3.2.19 / FBXW7 protein, human; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


23. Song JH, Schnittke N, Zaat A, Walsh CS, Miller CW: FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias. Leuk Res; 2008 Nov;32(11):1751-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
  • Mutations of FBXW7 have been found in human colorectal, ovarian, endometrial tumors and T-cell acute lymphocytic leukemias.
  • Prompted by these findings we have examined acute myeloid leukemia, non-Hodgkin's lymphoma, T-cell acute lymphocytic leukemia, B-cell acute lymphocytic leukemia and adult T-cell leukemia DNA for mutations of the FBXW7 gene.
  • As expected, mutations were found in T-cell acute lymphocytic leukemias.
  • However mutations of FBXW7 were also found in four of 118 B-cell acute lymphocytic leukemias and one of 24 adult T-cell leukemia samples.
  • These observations suggest that disruption of FBXW7 has a role in several forms of lymphocytic leukemias and not exclusively T-cell acute lymphocytic leukemia.
  • [MeSH-major] Burkitt Lymphoma / genetics. Cell Cycle Proteins / genetics. F-Box Proteins / genetics. Leukemia-Lymphoma, Adult T-Cell / genetics. Lymphoma, Non-Hodgkin / genetics. Mutation / genetics. Ubiquitin-Protein Ligases / genetics

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18485478.001).
  • [ISSN] 0145-2126
  • [Journal-full-title] Leukemia research
  • [ISO-abbreviation] Leuk. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / F-Box Proteins; EC 6.3.2.19 / FBXW7 protein, human; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


24. Porteous T, Bond C, Hannaford P, Sinclair H: How and why are non-prescription analgesics used in Scotland? Fam Pract; 2005 Feb;22(1):78-85
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] How and why are non-prescription analgesics used in Scotland?
  • OBJECTIVES: To estimate the prevalence of recent use of non-prescription analgesics in Scotland, to describe by whom they are used, and to estimate inappropriate use.
  • METHOD: A cross-sectional postal survey consisting of a self-completed questionnaire that collected data on respondents' use of non-prescription and prescription medicines, as well as demographic and lifestyle data.
  • Some 37% (555/1501) of respondents had used a non-prescription analgesic in the previous two weeks.
  • Analgesics accounted for 59% (636/1081) of all non-prescription medicines used in that period.
  • After controlling for all other variables, age, sex, level of education, self-reported health status, prescription exemption status, and use of prescription analgesics, remained significant predictors of non-prescription analgesic use.
  • There was evidence of possible inappropriate use of non-prescription analgesics including use of multiple analgesics (n=67), use by individuals self-reporting conditions associated with cautious use of certain analgesics (n=51), and potential drug-drug interactions (n=15).
  • A few respondents appeared to be using non-prescription analgesics to supplement medical treatment of chronic conditions (n=4).
  • CONCLUSIONS: Our findings have demonstrated a high level of use of non-prescription analgesics amongst the general public, with significant potential for inappropriate use.
  • As we move towards a culture of increased self-management of minor illness, this demonstrated need for improved pharmacovigilance of non-prescribed medicines must be addressed.
  • [MeSH-minor] Adult. Age Distribution. Aged. Alcohol Drinking / epidemiology. Cross-Sectional Studies. Female. Humans. Male. Middle Aged. Pharmacoepidemiology / methods. Prevalence. Primary Health Care. Scotland / epidemiology. Sex Distribution. Smoking / epidemiology. Surveys and Questionnaires

  • MedlinePlus Health Information. consumer health - Over-the-Counter Medicines.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15640291.001).
  • [ISSN] 0263-2136
  • [Journal-full-title] Family practice
  • [ISO-abbreviation] Fam Pract
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Analgesics; 0 / Nonprescription Drugs
  •  go-up   go-down


25. Lutgehetmann M, Meyer F, Volz T, Lohse AW, Fischer C, Dandri M, Petersen J: [Knowledge about HBV, prevention behaviour and treatment adherence of patients with chronic hepatitis B in a large referral centre in Germany]. Z Gastroenterol; 2010 Sep;48(9):1126-32
Genetic Alliance. consumer health - Hepatitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adult. Emigrants and Immigrants / statistics & numerical data. Female. Germany / epidemiology. Humans. Male. Prevalence. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Georg Thieme Verlag KG Stuttgart · New York.
  • (PMID = 20839162.001).
  • [ISSN] 1439-7803
  • [Journal-full-title] Zeitschrift für Gastroenterologie
  • [ISO-abbreviation] Z Gastroenterol
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


26. Gebuis T, Kenemans JL, de Haan EH, van der Smagt MJ: Conflict processing of symbolic and non-symbolic numerosity. Neuropsychologia; 2010 Jan;48(2):394-401

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conflict processing of symbolic and non-symbolic numerosity.
  • The present study investigates whether the neural activity underlying symbolic and non-symbolic numerosity processing interacts with the neural activity underlying physical size processing before, or proceeds independently until, selective activation of the motor system.
  • We used a symbolic (Arabic numbers) and non-symbolic (arrays of dots) size congruency task and instructed subjects to judge either the numerical or the physical size of the stimuli, while event related potentials were recorded.
  • [MeSH-minor] Adult. Cerebral Cortex / physiology. Electrocardiography / methods. Electroencephalography / methods. Female. Humans. Judgment / physiology. Male. Neuropsychological Tests. Photic Stimulation / methods. Reaction Time / physiology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2009 Elsevier Ltd. All rights reserved.
  • (PMID = 19804788.001).
  • [ISSN] 1873-3514
  • [Journal-full-title] Neuropsychologia
  • [ISO-abbreviation] Neuropsychologia
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


27. Strohm PC, Müller CA, Helwig P, Mohr B, Südkamp NP: [Is the locking, 3.5 mm Palmar T-Plate the implant of choice for displaced distal radius fractures?]. Z Orthop Unfall; 2007 May-Jun;145(3):331-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Compared with other investigations we must ask ourselves if the benefit of the locking plates justifies its use as compared with non-locking (conventional) plates.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Equipment Failure Analysis. Female. Humans. Male. Middle Aged. Prosthesis Design. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Arm Injuries and Disorders.
  • MedlinePlus Health Information. consumer health - Wrist Injuries and Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17607633.001).
  • [ISSN] 1864-6697
  • [Journal-full-title] Zeitschrift für Orthopädie und Unfallchirurgie
  • [ISO-abbreviation] Z Orthop Unfall
  • [Language] ger
  • [Publication-type] Clinical Trial; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


28. Rahmani M, Birouk N, Amarti A, Loukili Idrissi A, Marnissi F, Belaidi H, El Alaoui Faris M, Benchekroun S, Ouazzani R: [T-cell lymphoma revealed by a mononeuritis multiplex: case report and review of literature]. Rev Neurol (Paris); 2007 Apr;163(4):462-70
Genetic Alliance. consumer health - Mononeuritis multiplex.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a case in which mononeuritis multiplex (MM) was the dominant feature in the clinical presentation of a peripheral T-cell non-Hodgkin lymphoma (NHL).
  • [MeSH-minor] Adult. Anti-Inflammatory Agents / therapeutic use. Electrodiagnosis. Electrophysiology. Humans. Male. Median Nerve / physiopathology. Muscle, Skeletal / pathology. Nerve Fibers, Myelinated / pathology. Neurologic Examination

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17452948.001).
  • [ISSN] 0035-3787
  • [Journal-full-title] Revue neurologique
  • [ISO-abbreviation] Rev. Neurol. (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents
  •  go-up   go-down


29. Poenitz N, Simon-Ackermann J, Gratchev A, Qadoumi M, Klemke CD, Stadler R, Kremer A, Radenhausen M, Henke U, Assaf C, Utikal J, Goerdt S, Dippel E: Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Dermatology; 2005;211(2):84-92
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
  • OBJECTIVE: Our study was performed in order to evaluate c-myb expression as a quantitative parameter for differential diagnosis in leukaemic and non-leukaemic variants of CTCL.
  • CONCLUSION: Overexpression of c-myb in skin lesions of both non-leukaemic and leukaemic CTCL independent of the stage of the disease indicates that it acts early in disease development.
  • [MeSH-minor] Adult. Age Factors. Aged. Aged, 80 and over. Blotting, Southern. Case-Control Studies. Cohort Studies. Female. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. Male. Middle Aged. Mycosis Fungoides / blood. Mycosis Fungoides / genetics. Mycosis Fungoides / pathology. Neoplasm Staging. Prognosis. Reference Values. Reverse Transcriptase Polymerase Chain Reaction. Risk Assessment. Sensitivity and Specificity. Sex Factors. Sezary Syndrome / genetics. Sezary Syndrome / mortality. Sezary Syndrome / pathology

  • Genetic Alliance. consumer health - Cutaneous T-Cell Lymphoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2005 S. Karger AG, Basel
  • (PMID = 16088151.001).
  • [ISSN] 1018-8665
  • [Journal-full-title] Dermatology (Basel, Switzerland)
  • [ISO-abbreviation] Dermatology (Basel)
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


30. Abe H, Yoshizawa K, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y: Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol; 2008;43(12):967-74
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo.
  • The clinical characteristics of non-B non-C HCC patients were examined to determine possible carcinogenic factors.
  • RESULTS: Of 320 HCC patients, 64 were classified as having non-B non-C HCC.
  • The proportion of non-B non-C HCC increased from 17.8% in 2000 to 28.6% in 2006.
  • Non-B non-C HCC patients had a significantly higher rate of early stage cirrhosis (Child-Pugh classification) than viral HCC patients.
  • Significantly fewer non-B non-C HCC patients had periodic intensive medical assessments than viral HCC patients.
  • Forty-five non-B non-C HCC patients were habitual alcohol drinkers, ten had nonalcoholic fatty liver disease (NAFLD), and seven had no apparent etiology.
  • CONCLUSIONS: Alcohol consumption and NAFLD may be important etiological factors in non-B non-C HCC.
  • Periodic medical assessments for all patients with non-B non-C cirrhosis are crucial for early diagnosis and curative therapy.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Alcohol Drinking / adverse effects. Fatty Liver / complications. Fatty Liver / epidemiology. Female. Humans. Liver Cirrhosis / complications. Liver Cirrhosis / epidemiology. Liver Diseases / complications. Liver Diseases / epidemiology. Male. Middle Aged. Severity of Illness Index. Tokyo / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hepatology. 1993 Jul;18(1):47-53 [7686879.001]
  • [Cites] Intervirology. 2006;49(1-2):7-17 [16166783.001]
  • [Cites] Hepatology. 2000 Oct;32(4 Pt 1):689-92 [11003611.001]
  • [Cites] Hepatology. 1999 Dec;30(6):1356-62 [10573511.001]
  • [Cites] Hepatol Res. 2002 Feb;22(2):139-144 [11818253.001]
  • [Cites] Hepatol Res. 2004 Jan;28(1):21-29 [14734147.001]
  • [Cites] Alcohol Clin Exp Res. 1996 Dec;20(9 Suppl):378A-382A [8986242.001]
  • [Cites] Pathol Int. 2001 Feb;51(2):127-31 [11169153.001]
  • [Cites] Int J Mol Med. 2000 Dec;6(6):661-5 [11078825.001]
  • [Cites] Br J Cancer. 1994 Nov;70(5):950-3 [7947103.001]
  • [Cites] Lancet. 1995 Oct 21;346(8982):1051-5 [7564784.001]
  • [Cites] J Hepatol. 2001 Sep;35(3):421-30 [11592607.001]
  • [Cites] Alcohol Clin Exp Res. 2003 Aug;27(8 Suppl):32S-36S [12960504.001]
  • [Cites] Alcohol. 2005 Apr;35(3):155-60 [16054976.001]
  • [Cites] Hepatology. 2002 Nov;36(5):1206-13 [12395331.001]
  • [Cites] Hepatology. 2000 Dec;32(6):1216-23 [11093727.001]
  • [Cites] J Hepatol. 2000 Nov;33(5):785-90 [11097488.001]
  • [Cites] Semin Liver Dis. 1999;19(2):221-9 [10422202.001]
  • [Cites] Cancer. 2000 Jul 1;89(1):53-9 [10897000.001]
  • [Cites] Cancer Causes Control. 1991 Sep;2(5):307-14 [1932543.001]
  • [Cites] J Hepatol. 2002 Jul;37(1):154-60 [12076877.001]
  • [Cites] Br J Surg. 1973 Aug;60(8):646-9 [4541913.001]
  • [Cites] Hepatology. 1999 Mar;29(3):664-9 [10051466.001]
  • [Cites] Am J Gastroenterol. 2000 Oct;95(10):3018-9 [11051414.001]
  • [Cites] Diabetes Metab Res Rev. 2001 Sep-Oct;17(5):374-9 [11747142.001]
  • [Cites] Hepatol Res. 2000 Nov;18(3):252-266 [11058829.001]
  • [Cites] Intern Med. 2003 May;42(5):389-93 [12793707.001]
  • [Cites] JAMA. 2006 Jan 4;295(1):65-73 [16391218.001]
  • [Cites] Dig Dis Sci. 2002 Apr;47(4):710-5 [11991597.001]
  • [Cites] Scand J Gastroenterol. 2000 Aug;35(8):889-93 [10994630.001]
  • [Cites] Am J Gastroenterol. 2001 Aug;96(8):2462-7 [11513191.001]
  • [Cites] J Infect Dis. 2000 Jun;181(6):1920-8 [10837171.001]
  • [Cites] J Gastroenterol Hepatol. 2000 Oct;15(10):1205-11 [11106103.001]
  • [Cites] J Natl Cancer Inst. 2000 Jul 5;92(13):1096-9 [10880555.001]
  • (PMID = 19107341.001).
  • [ISSN] 0944-1174
  • [Journal-full-title] Journal of gastroenterology
  • [ISO-abbreviation] J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


31. Chappaz S, Flueck L, Farr AG, Rolink AG, Finke D: Increased TSLP availability restores T- and B-cell compartments in adult IL-7 deficient mice. Blood; 2007 Dec 1;110(12):3862-70
Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased TSLP availability restores T- and B-cell compartments in adult IL-7 deficient mice.
  • Interleukin 7 (IL-7) plays a crucial role in adult lymphopoiesis, while in fetal life its effect can be partially compensated by TSLP.
  • Whether adult hematopoietic progenitor cells are unresponsive to TSLP or whether TSLP is less available in adult microenvironments is still a matter of debate.
  • Analysis of bone marrow chimeras demonstrated that hematopoietic progenitor cells from adult wild-type mice efficiently differentiated toward B- and T-cell lineages in lethally irradiated IL-7 deficient mice provided TSLP Tg was expressed in these mice.
  • In vitro, TSLP promoted the differentiation of uncommitted adult bone marrow progenitors toward B and T lineages and the further differentiation of DN1 and DN2 thymocytes.
  • Altogether, our results show that adult hematopoietic cells are TSLP responsive and that TSLP can sustain long-term adult lymphopoiesis.

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17702899.001).
  • [ISSN] 0006-4971
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cytokines; 0 / Interleukin-7; 0 / Receptors, Antigen, T-Cell, alpha-beta; 0 / thymic stromal lymphopoietin
  •  go-up   go-down


32. Aref S, Mossad Y, El-Khodary T, Awad M, El-Shahat E: Cyclin Dl expression in B-cell non Hodgkin lymphoma. Hematology; 2006 Oct;11(5):365-70
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cyclin Dl expression in B-cell non Hodgkin lymphoma.
  • Over-expression of cyclin D1 protein has been reported in several solid tumors and certain lymphoid malignancies, but little is known about the effect of its expression on clinical behavior and outcome in B-cell Non-Hodgkin lymphoma (NHL).
  • [MeSH-minor] Adult. Aged. Case-Control Studies. Female. Humans. Lymphatic Diseases. Male. Middle Aged. Prognosis. Up-Regulation


33. Takahashi Y, Kubota Y, Yamasaki E, Matsuda K: [Rasmussen encephalitis and non-herpetic acute limbic encephalitis]. Rinsho Shinkeigaku; 2008 Mar;48(3):163-72
MedlinePlus Health Information. consumer health - Encephalitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Rasmussen encephalitis and non-herpetic acute limbic encephalitis].
  • Rasmussen syndrome (RS) and non-herpetic acute limbic encephalitis (NHALE) have pathophysiological background related with autoimmunity to glutamate receptors (GluRs) after infections.
  • Our study in 91 adult patients with NHALE revealed the following characteristics.
  • Autoantibodies against GluRepsilon2 in sera were detected in approximately 60% of NHALE patients from acute to chronic stages, and the autoantibodies in CSF were detected in 51.8% (acute stage), 41.4% (recovery stage), 28.6% (chronic stage) of patients and included epitopes to n-terminal of GluRepsilon2 (NT1).
  • These data suggest that autoantibodies against GluRepsilon2 produced in sera after infection infiltrate into CNS through damaged BBB in acute stages, and affect n-terminal of GluRepsilon2.
  • [MeSH-minor] Acute Disease. Adolescent. Adult. Age Factors. Animals. Autoantibodies. Humans. Middle Aged. Receptors, Glutamate / immunology. T-Lymphocytes, Cytotoxic / immunology

  • Genetic Alliance. consumer health - Limbic encephalitis.
  • Genetic Alliance. consumer health - Rasmussen encephalitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18409535.001).
  • [ISSN] 0009-918X
  • [Journal-full-title] Rinshō shinkeigaku = Clinical neurology
  • [ISO-abbreviation] Rinsho Shinkeigaku
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Autoantibodies; 0 / Receptors, Glutamate
  • [Number-of-references] 39
  •  go-up   go-down


34. Bienert M, Reisinger I, Srock S, Humplik BI, Reim C, Kroessin T, Avril N, Pezzutto A, Munz DL: Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma: initial experience. Eur J Nucl Med Mol Imaging; 2005 Oct;32(10):1225-33
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma: initial experience.
  • PURPOSE: The aim of this study was to evaluate the safety, toxicity and therapeutic response of non-myeloablative radioimmunotherapy using 131I-rituximab in previously heavily treated patients with B-cell non-Hodgkin's lymphoma (B-NHL).
  • RESULTS: No acute adverse effects were observed after the administration of 131I-rituximab.
  • Four non-responders with bulky disease died 4.8+/-2.0 months after therapy.
  • [MeSH-minor] Adult. Aged. Antibodies, Monoclonal, Murine-Derived. Female. Humans. Male. Middle Aged. Pilot Projects. Radiation Injuries / etiology. Radiopharmaceuticals / adverse effects. Radiopharmaceuticals / therapeutic use. Severity of Illness Index. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2003 Apr 1;21(7):1263-70 [12663713.001]
  • [Cites] J Clin Oncol. 1999 Apr;17(4):1244 [10561185.001]
  • [Cites] Cancer Pract. 1998 May-Jun;6(3):195-7 [9652253.001]
  • [Cites] J Clin Oncol. 1997 Apr;15(4):1587-94 [9193357.001]
  • [Cites] Cancer. 2002 Feb 15;94(4 Suppl):1363-72 [11877767.001]
  • [Cites] Clin Immunol. 2001 Jul;100(1):40-8 [11414744.001]
  • [Cites] Semin Oncol. 1999 Oct;26(5 Suppl 14):58-65 [10561019.001]
  • [Cites] J Clin Oncol. 2002 May 15;20(10 ):2453-63 [12011122.001]
  • [Cites] Blood. 2000 Aug 15;96(4):1259-66 [10942366.001]
  • [Cites] Nuklearmedizin. 2002 Apr;41(2):71-9 [11989301.001]
  • [Cites] Lancet. 1995 Aug 5;346(8971):336-40 [7623531.001]
  • [Cites] J Nucl Med. 1990 Jan;31(1):84-9 [2295945.001]
  • [Cites] N Engl J Med. 1993 Apr 8;328(14):1023-30 [8450856.001]
  • [Cites] Clin Cancer Res. 1999 Oct;5(10 Suppl):3281s-3286s [10541376.001]
  • [Cites] J Clin Oncol. 1999 Jan;17(1):268-76 [10458242.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2002 Oct;29(10 ):1276-82 [12271407.001]
  • [Cites] J Clin Oncol. 1996 Jul;14 (7):1974-81 [8683227.001]
  • [Cites] J Nucl Med. 1998 Aug;39(8 Suppl):21S-27S [9708567.001]
  • [Cites] J Clin Oncol. 1998 Oct;16(10):3246-56 [9779698.001]
  • [Cites] J Clin Oncol. 1999 Dec;17(12):3793-803 [10577851.001]
  • [Cites] Lancet Oncol. 2004 Jun;5(6):341-53 [15172354.001]
  • [Cites] Cancer Biother Radiopharm. 2003 Aug;18(4):513-24 [14503945.001]
  • [Cites] Clin Cancer Res. 1999 Oct;5(10 Suppl):3304s-3314s [10541379.001]
  • [Cites] N Engl J Med. 1993 Oct 21;329(17):1219-24 [7692295.001]
  • [Cites] Cancer Immunol Immunother. 2003 May;52(5):281-96 [12700944.001]
  • [Cites] J Clin Oncol. 1986 Oct;4(10):1470-80 [3531422.001]
  • [Cites] Eur J Nucl Med. 2000 Jul;27(7):766-77 [10952488.001]
  • [Cites] J Clin Oncol. 1998 Oct;16(10 ):3270-8 [9779701.001]
  • [Cites] N Engl J Med. 2002 Jan 24;346(4):235-42 [11807147.001]
  • [Cites] J Clin Oncol. 1989 Aug;7(8):1027-38 [2666588.001]
  • [Cites] Eur J Haematol. 2004 Jan;72(1):10-7 [14962257.001]
  • [Cites] J Clin Oncol. 1998 Aug;16(8):2825-33 [9704735.001]
  • [Cites] J Clin Oncol. 1992 Nov;10 (11):1696-711 [1403053.001]
  • [Cites] J Clin Oncol. 2002 Aug 1;20(15):3262-9 [12149300.001]
  • (PMID = 15937686.001).
  • [ISSN] 1619-7070
  • [Journal-full-title] European journal of nuclear medicine and molecular imaging
  • [ISO-abbreviation] Eur. J. Nucl. Med. Mol. Imaging
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / 131I-rituximab; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Radiopharmaceuticals
  •  go-up   go-down


35. Alvarez-Busto I, Albers A, Visus MC, Mayordomo JI, Sanz J, Burillo MA, Güemes A, García-Prats MD, Moros M, De Leo A, Tres A: [Detection of specific T cells for 264-272 and 149-157 peptides of p53 protein in peripheral blood of patients with breast cancer]. Med Clin (Barc); 2008 Nov 22;131(18):685-8
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Lymphocyte Count. Middle Aged

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19087825.001).
  • [ISSN] 0025-7753
  • [Journal-full-title] Medicina clínica
  • [ISO-abbreviation] Med Clin (Barc)
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


36. Haagsman A, Reuter G, Duizer E, Nagy G, Herremans T, Koopmans M, Szücs G: Seroepidemiology of hepatitis E virus in patients with non-A, non-B, non-C hepatitis in Hungary. J Med Virol; 2007 Jul;79(7):927-30
Genetic Alliance. consumer health - Hepatitis E.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Seroepidemiology of hepatitis E virus in patients with non-A, non-B, non-C hepatitis in Hungary.
  • Many cases of acute hepatitis remain undiagnosed and the hepatitis E virus (HEV) is emerging in industrialized countries.
  • The aim of this study was to assess the role HEV as causative agent in acute non-A, non-B, and non-C hepatitis patients in Hungary.
  • 10.5% of the 264 acute non-A, non-B, and non-C hepatitis patients tested had anti-HEV IgG and 1.9% had anti-HEV IgM as tested by ELISA.
  • After confirmation by Western blot 6.1% of the acute non-A, non-B, and non-C hepatitis patients had anti-HEV IgG antibodies only and 1.1% of the patients had both IgG and IgM.
  • Only a small proportion of the acute hepatitis cases in the southwest of Hungary are assumed to be attributed to HEV infection, however, hepatitis E should be considered along with hepatitis A, B, and C in the diagnosis of acute hepatitis.
  • [MeSH-minor] Acute Disease. Adult. Aged. Aged, 80 and over. Female. Hepatitis Antibodies / blood. Humans. Hungary / epidemiology. Immunoglobulin G / blood. Immunoglobulin M / blood. Male. Middle Aged. Molecular Epidemiology. Seroepidemiologic Studies

  • Genetic Alliance. consumer health - Hepatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17516521.001).
  • [ISSN] 0146-6615
  • [Journal-full-title] Journal of medical virology
  • [ISO-abbreviation] J. Med. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Hepatitis Antibodies; 0 / Immunoglobulin G; 0 / Immunoglobulin M
  •  go-up   go-down


37. Detry-Morel M, Detry MB: Five-year experience with non penetrating deep sclerectomy. Bull Soc Belge Ophtalmol; 2006;(299):83-94
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Five-year experience with non penetrating deep sclerectomy.
  • PURPOSE: To assess the long-term safety and effectiveness of non penetrating deep sclerectomy (DS) and to compare the incidence and the severity of postoperative complications and the IOP results according to surgical adjuvants (implant device, antimetabolite or both) were used or not.
  • MATERIAL-METHODS: Retrospective non randomised study including 171 eyes (136 patients), mean age: 63.9 years) with medically uncontrolled open-angle glaucoma and without previous filtering surgery.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Infant. Intraoperative Care. Male. Middle Aged. Postoperative Care. Postoperative Complications / epidemiology. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Glaucoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16681091.001).
  • [ISSN] 0081-0746
  • [Journal-full-title] Bulletin de la Société belge d'ophtalmologie
  • [ISO-abbreviation] Bull Soc Belge Ophtalmol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


38. Yi WS, Xu XL, Xiang Q, Jiang HB: [Characteristics of ocular adnexal non-Hodgkin lymphoma]. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep;33(9):826-30
MedlinePlus Health Information. consumer health - Eye Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Characteristics of ocular adnexal non-Hodgkin lymphoma].
  • OBJECTIVE: To investigate the clinical manifestation and pathological features of primary ocular adnexal non-Hodgkin lymphoma.
  • METHODS: Data of 18 patients with biopsy-proven ocular adnexal non-Hodgkin lymphoma at Xiangya hospital were reviewed.The disease site, clinical manifestation,imaging and pathological features of the tumor were summarized.
  • The diagnosis of ocular adnexal non-Hodgkin lymphoma is difficult which could easily be misdiagnosed as "inflammatory pseudotumour".
  • [MeSH-major] Eye Neoplasms / diagnosis. Lymphoma, Non-Hodgkin / diagnosis. Orbital Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Diagnosis, Differential. Female. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Hodgkin lymphoma.
  • Genetic Alliance. consumer health - Non-Hodgkin Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18812662.001).
  • [ISSN] 1672-7347
  • [Journal-full-title] Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
  • [ISO-abbreviation] Zhong Nan Da Xue Xue Bao Yi Xue Ban
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


39. Shimizu D, Taki T, Utsunomiya A, Nakagawa H, Nomura K, Matsumoto Y, Nishida K, Horiike S, Taniwaki M: Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma. Int J Hematol; 2007 Apr;85(3):212-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma.
  • We analyzed NOTCH1 gene mutation in 53 adults with mature T-cell leukemia/lymphoma: 21 patients with adult T-cell leukemia (ATL), 25 with T-cell non-Hodgkin's lymphoma (T-NHL), and 7 with T-cell prolymphocytic leukemia.
  • These findings suggest that nonsense mutation in the PEST domain in the ATL case was associated with NOTCH1 signaling through a pathway different from that for T-cell acute lymphoblastic leukemia (T-ALL).
  • Although NOTCH1 mutation occurs infrequently in mature T-cell leukemia/lymphoma, NOTCH1 may be involved in leukemogenesis associated with various forms of T-cell leukemia/lymphoma rather than only with T-ALL.
  • [MeSH-major] Codon, Nonsense. Leukemia-Lymphoma, Adult T-Cell / genetics. Lymphoma, T-Cell, Peripheral / genetics. Receptor, Notch1 / genetics
  • [MeSH-minor] Adult. DNA Mutational Analysis. Humans

  • Genetic Alliance. consumer health - Peripheral T-cell lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 2004 Sep 15;104(6):1696-702 [15187027.001]
  • [Cites] Blood. 2002 May 1;99(9):3398-403 [11964309.001]
  • [Cites] Cell. 1991 Aug 23;66(4):649-61 [1831692.001]
  • [Cites] J Biol Chem. 2001 Sep 14;276(37):34371-8 [11425854.001]
  • [Cites] Mol Cell Biol. 2000 Oct;20(20):7505-15 [11003647.001]
  • [Cites] Virchows Arch. 2005 Apr;446(4):416-20 [15756589.001]
  • [Cites] Int J Hematol. 2005 Nov;82(4):277-84 [16298815.001]
  • [Cites] Ann Oncol. 2004 Jul;15(7):1091-6 [15205204.001]
  • [Cites] Int J Hematol. 2005 Nov;82(4):295-301 [16298817.001]
  • [Cites] Science. 2004 Oct 8;306(5694):269-71 [15472075.001]
  • [Cites] Mol Cell Biol. 2003 Jan;23(2):655-64 [12509463.001]
  • [Cites] Leukemia. 2006 Mar;20(3):537-9 [16424867.001]
  • [Cites] Blood. 2006 Feb 15;107(4):1255-64 [16210342.001]
  • [Cites] Leukemia. 2005 Oct;19(10):1841-3 [16079893.001]
  • [Cites] Blood. 2000 Sep 1;96(5):1906-13 [10961893.001]
  • [Cites] Blood. 2006 Mar 15;107(6):2540-3 [16282337.001]
  • [Cites] Immunity. 1999 Sep;11(3):299-308 [10514008.001]
  • [Cites] Blood. 2006 Jan 15;107(2):781-5 [16166587.001]
  • [Cites] Science. 1999 Apr 30;284(5415):770-6 [10221902.001]
  • [Cites] Br J Haematol. 1999 Sep;106(3):702-5 [10468859.001]
  • [Cites] Blood. 2004 Dec 1;104(12 ):3697-704 [15292061.001]
  • [Cites] Nat Immunol. 2005 Jul;6(7):680-8 [15991363.001]
  • [Cites] Nature. 2005 Sep 8;437(7056):270-4 [16025100.001]
  • [Cites] Blood. 1994 Jan 15;83(2):505-11 [8286748.001]
  • [Cites] Blood. 2004 Nov 15;104(10):3097-105 [15251982.001]
  • [Cites] Electrophoresis. 2001 Oct;22(18):4016-22 [11700735.001]
  • [Cites] Pathol Int. 2000 Sep;50(9):696-702 [11012982.001]
  • [Cites] Mol Cell Biol. 2006 Jun;26(12):4642-51 [16738328.001]
  • [Cites] Cell. 1997 Mar 21;88(6):833-43 [9118226.001]
  • [Cites] Blood. 2004 Jul 15;104(2):328-35 [15044256.001]
  • [Cites] Mol Cell Biol. 2000 Jun;20(11):3928-41 [10805736.001]
  • [Cites] Cancer Genet Cytogenet. 2000 Feb;117(1):71-9 [10700871.001]
  • [Cites] Blood. 2005 Dec 1;106(12):3898-906 [16118316.001]
  • [Cites] Trends Biochem Sci. 1996 Jul;21(7):267-71 [8755249.001]
  • [Cites] Cell. 2004 May 14;117(4):515-26 [15137944.001]
  • [Cites] Blood. 2006 Aug 15;108(4):1151-7 [16614245.001]
  • [Cites] Blood. 1997 Jun 1;89(11):3909-18 [9166827.001]
  • [Cites] Clin Cancer Res. 2006 May 15;12(10):3043-9 [16707600.001]
  • [Cites] Leukemia. 2003 Apr;17(4):738-45 [12682631.001]
  • [Cites] Cell. 1996 Nov 1;87(3):483-92 [8898201.001]
  • [Cites] Leukemia. 2001 Oct;15(10):1627-32 [11587222.001]
  • [Cites] Mol Cell Biol. 2004 Nov;24(21):9265-73 [15485896.001]
  • [Cites] Blood. 2001 Dec 15;98(13):3793-9 [11739188.001]
  • (PMID = 17483057.001).
  • [ISSN] 0925-5710
  • [Journal-full-title] International journal of hematology
  • [ISO-abbreviation] Int. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Codon, Nonsense; 0 / NOTCH1 protein, human; 0 / Receptor, Notch1
  •  go-up   go-down


40. Tosello V, Mansour MR, Barnes K, Paganin M, Sulis ML, Jenkinson S, Allen CG, Gale RE, Linch DC, Palomero T, Real P, Murty V, Yao X, Richards SM, Goldstone A, Rowe J, Basso G, Wiernik PH, Paietta E, Pieters R, Horstmann M, Meijerink JP, Ferrando AA: WT1 mutations in T-ALL. Blood; 2009 Jul 30;114(5):1038-45
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The molecular mechanisms involved in disease progression and relapse in T-cell acute lymphoblastic leukemia (T-ALL) are poorly understood.
  • Subsequent analysis showed WT1 mutations in 28 of 211 (13.2%) of pediatric and 10 of 85 (11.7%) of adult T-ALL cases.
  • Survival analysis demonstrated that WT1 mutations do not confer adverse prognosis in pediatric and adult T-ALL.
  • [MeSH-major] Genes, Wilms Tumor. Mutation. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • [MeSH-minor] Adult. Child. Chromosome Aberrations. Clone Cells / chemistry. DNA Methylation. DNA Mutational Analysis. DNA, Neoplasm / genetics. Disease Progression. Genes, Homeobox. Humans. Kaplan-Meier Estimate. Neoplasm Proteins / chemistry. Neoplasm Proteins / genetics. Oncogenes. Polymorphism, Single Nucleotide. Prognosis. Recurrence. WT1 Proteins / chemistry. WT1 Proteins / genetics. Zinc Fingers / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6010-4 [1321431.001]
  • [Cites] Cell. 1991 Aug 23;66(4):649-61 [1831692.001]
  • [Cites] Hum Mol Genet. 1993 Mar;2(3):259-64 [8388765.001]
  • [Cites] Blood. 1994 May 15;83(10):2922-30 [8180387.001]
  • [Cites] Hum Mol Genet. 1995 Mar;4(3):351-8 [7795587.001]
  • [Cites] Blood. 1996 Mar 15;87(6):2171-9 [8630376.001]
  • [Cites] Hum Mutat. 1997;9(3):209-25 [9090524.001]
  • [Cites] Nucleic Acids Res. 1997 Jun 15;25(12):2532-4 [9171110.001]
  • [Cites] Eur J Haematol. 1997 May;58(5):346-9 [9222290.001]
  • [Cites] Blood. 1998 Apr 15;91(8):2961-8 [9531607.001]
  • [Cites] Kidney Int. 1998 Jun;53(6):1512-8 [9607183.001]
  • [Cites] Blood. 2005 Jul 1;106(1):274-86 [15774621.001]
  • [Cites] Pediatr Blood Cancer. 2006 Jan;46(1):18-25 [15929133.001]
  • [Cites] Leukemia. 2006 Jul;20(7):1279-87 [16688224.001]
  • [Cites] Haematologica. 2006 Sep;91(9):1212-21 [16956820.001]
  • [Cites] Leukemia. 2007 Mar;21(3):550-1; author reply 552 [17205055.001]
  • [Cites] Nature. 2007 Apr 12;446(7137):758-64 [17344859.001]
  • [Cites] Nat Genet. 2007 May;39(5):593-5 [17435759.001]
  • [Cites] Leukemia. 2007 Jun;21(6):1258-66 [17443227.001]
  • [Cites] Blood. 2007 Aug 15;110(4):1251-61 [17452517.001]
  • [Cites] J Exp Med. 2007 Aug 6;204(8):1825-35 [17646408.001]
  • [Cites] J Exp Med. 2007 Aug 6;204(8):1813-24 [17646409.001]
  • [Cites] Cancer Res. 2007 Oct 1;67(19):9006-12 [17909001.001]
  • [Cites] Oncogene. 2007 Oct 15;26(47):6838-49 [17934490.001]
  • [Cites] Clin Cancer Res. 2007 Dec 1;13(23):6964-9 [18056171.001]
  • [Cites] J Exp Med. 2007 Dec 24;204(13):3059-66 [18070937.001]
  • [Cites] Leukemia. 2008 Jan;22(1):124-31 [17928886.001]
  • [Cites] Nat Rev Cancer. 2008 Feb;8(2):83-93 [18094723.001]
  • [Cites] Lancet. 2008 Mar 22;371(9617):1030-43 [18358930.001]
  • [Cites] Leukemia. 2008 Apr;22(4):762-70 [18185524.001]
  • [Cites] Nat Rev Immunol. 2008 May;8(5):380-90 [18421304.001]
  • [Cites] Blood. 2008 May 1;111(9):4668-80 [18299449.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 May 6;105(18):6708-13 [18458336.001]
  • [Cites] Blood. 2008 Aug 1;112(3):733-40 [18411416.001]
  • [Cites] J Clin Oncol. 2008 Oct 1;26(28):4595-602 [18559874.001]
  • [Cites] J Clin Oncol. 2008 Nov 20;26(33):5429-35 [18591546.001]
  • [Cites] Science. 2008 Nov 28;322(5906):1377-80 [19039135.001]
  • [Cites] Semin Hematol. 2000 Oct;37(4):381-95 [11071360.001]
  • [Cites] Genome Biol. 2001;2(8):RESEARCH0032 [11532216.001]
  • [Cites] Leukemia. 2001 Oct;15(10):1495-504 [11587205.001]
  • [Cites] J Pediatr Hematol Oncol. 2001 Oct;23(7):416-9 [11878574.001]
  • [Cites] Cancer Cell. 2002 Feb;1(1):75-87 [12086890.001]
  • [Cites] N Engl J Med. 2004 Apr 8;350(15):1535-48 [15071128.001]
  • [Cites] Nat Genet. 2004 Oct;36(10):1084-9 [15361874.001]
  • [Cites] Science. 2004 Oct 8;306(5694):269-71 [15472075.001]
  • [Cites] Clin Nephrol. 1985 Dec;24(6):269-78 [3000666.001]
  • [Cites] Genomics. 1989 Nov;5(4):685-93 [2556343.001]
  • [Cites] Cell. 1990 Jun 29;61(7):1257-69 [2163761.001]
  • [Cites] FEBS Lett. 1993 Feb 8;317(1-2):39-43 [8381368.001]
  • (PMID = 19494353.001).
  • [ISSN] 1528-0020
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] eng
  • [Databank-accession-numbers] GEO/ GSE15931
  • [Grant] United States / NCI NIH HHS / CA / CA114737; United Kingdom / Medical Research Council / / MC/ U137686856; United States / NCI NIH HHS / CA / R01 CA129382; United Kingdom / Medical Research Council / / ; United States / NCI NIH HHS / CA / CA02111; United Kingdom / Medical Research Council / / G0500389; United States / NCI NIH HHS / CA / R01CA120196; United States / NCI NIH HHS / CA / R01CA129382; United States / NCI NIH HHS / CA / R01 CA120196; United States / NCI NIH HHS / CA / U24 CA114737; United States / NCI NIH HHS / CA / R01 CA120196-03
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Neoplasm Proteins; 0 / WT1 Proteins
  • [Other-IDs] NLM/ PMC2721784
  •  go-up   go-down


41. Mitterlechner T, Fiegl M, Mühlböck H, Oberaigner W, Dirnhofer S, Tzankov A: Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000. J Clin Pathol; 2006 Jan;59(1):48-55
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.
  • AIMS: To analyse the entity specific incidence and disease specific survival (DSS) of non-Hodgkin lymphomas (NHLs) in Tyrol/Austria, 1991-2000.
  • Except for 29 cases of small lymphocytic (CLL/SLL), lymphoblastic leukaemia (ALL), and myeloma (MM), which were diagnosed cytologically, diagnoses were reclassified on paraffin wax embedded archival material according to new World Health Organisation criteria.
  • [MeSH-major] Lymphoma, Non-Hodgkin / epidemiology
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Austria / epidemiology. Child. Child, Preschool. Epidemiologic Methods. Female. Humans. Infant. Infant, Newborn. Male. Middle Aged. Sex Distribution

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Natl Cancer Inst. 2000 Aug 2;92(15):1240-51 [10922409.001]
  • [Cites] Am J Epidemiol. 1998 Nov 1;148(9):833-41 [9801013.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):361-8 [11319177.001]
  • [Cites] J Natl Cancer Inst. 2001 Jun 6;93(11):824-42 [11390532.001]
  • [Cites] Oncologist. 2001;6(3):247-56 [11423671.001]
  • [Cites] Curr Opin Hematol. 2002 Jan;9(1):50-5 [11753078.001]
  • [Cites] J Occup Environ Med. 2002 May;44(5):469-74 [12024692.001]
  • [Cites] Biomed Pharmacother. 2002 Jul;56(5):223-34 [12199621.001]
  • [Cites] Br J Haematol. 2002 Sep;118(4):1071-7 [12199787.001]
  • [Cites] Dtsch Med Wochenschr. 2002 Oct 25;127(43):2253-8 [12397539.001]
  • [Cites] J Clin Pathol. 2002 Dec;55(12):892 [12461049.001]
  • [Cites] J Mol Cell Cardiol. 2002 Dec;34(12):1595-607 [12505058.001]
  • [Cites] J Clin Pathol. 2003 Mar;56(3):193 [12610096.001]
  • [Cites] Blood. 2003 Apr 15;101(8):3181-7 [12515730.001]
  • [Cites] Leuk Lymphoma. 2003 Mar;44(3):451-8 [12688314.001]
  • [Cites] Can J Gastroenterol. 2003 Jun;17 Suppl B:49B-52B [12845352.001]
  • [Cites] Autoimmun Rev. 2003 May;2(3):119-25 [12848952.001]
  • [Cites] Blood. 2003 Aug 1;102(3):996-9 [12714514.001]
  • [Cites] Int J Cancer. 2003 Oct 20;107(1):99-105 [12925963.001]
  • [Cites] Environ Health Perspect. 2003 Nov;111(14):1704-6 [14594618.001]
  • [Cites] Br J Haematol. 2004 May;125(3):294-317 [15086411.001]
  • [Cites] Ann Oncol. 2004 Aug;15(8):1215-21 [15277261.001]
  • [Cites] Adv Anat Pathol. 2004 Sep;11(5):227-38 [15322489.001]
  • [Cites] Blood. 1976 Jul;48(1):41-51 [820387.001]
  • [Cites] Int J Cancer. 1990 Oct 15;46(4):755-6 [2210891.001]
  • [Cites] Int J Cancer. 1992 Jan 2;50(1):163-4 [1728608.001]
  • [Cites] Am J Public Health. 1992 Jul;82(7):990-7 [1609918.001]
  • [Cites] Cancer Res. 1992 Oct 1;52(19 Suppl):5432s-5440s [1394149.001]
  • [Cites] Cancer Res. 1992 Oct 1;52(19 Suppl):5453s-5455s [1394153.001]
  • [Cites] Cancer Res. 1992 Oct 1;52(19 Suppl):5465s-5467s [1327508.001]
  • [Cites] Semin Diagn Pathol. 1992 Nov;9(4):297-303 [1480852.001]
  • [Cites] Lancet. 1993 Sep 4;342(8871):575-7 [8102719.001]
  • [Cites] Cancer Res. 1994 May 1;54(9):2386-9 [8162585.001]
  • [Cites] Blood. 1994 Sep 1;84(5):1361-92 [8068936.001]
  • [Cites] Am J Pathol. 1998 Dec;153(6):1707-15 [9846961.001]
  • [Cites] Semin Hematol. 1999 Apr;36(2):155-63 [10319384.001]
  • [Cites] Eur J Cancer. 1999 Apr;35(4):627-33 [10492638.001]
  • [Cites] Eur J Cancer. 1999 May;35(5):698-706 [10505027.001]
  • [Cites] Int J Cancer. 1999 Nov 12;83(4):481-5 [10508483.001]
  • [Cites] Immunology. 2005 Jan;114(1):37-43 [15606793.001]
  • [Cites] Transfus Med Rev. 2000 Jul;14(3):258-68 [10914420.001]
  • [Cites] J Natl Cancer Inst. 1999 Oct 20;91(20):1751-8 [10528026.001]
  • [Cites] Semin Oncol. 1999 Oct;26(5 Suppl 14):12-20 [10561013.001]
  • [Cites] Semin Oncol. 1999 Oct;26(5 Suppl 14):21-5 [10561014.001]
  • [Cites] Cancer Causes Control. 1999 Dec;10(6):617-25 [10616830.001]
  • [Cites] Br J Cancer. 1994 Oct;70(4):713-5 [7917925.001]
  • [Cites] Occup Environ Med. 1995 Jun;52(6):374-9 [7627313.001]
  • [Cites] J Natl Cancer Inst. 1996 May 15;88(10):675-9 [8627644.001]
  • [Cites] Blood. 1996 May 15;87(10):4296-301 [8639788.001]
  • [Cites] Eur J Cancer. 1996 Sep;32A(10):1753-7 [8983286.001]
  • [Cites] Ann Intern Med. 1997 Sep 1;127(5):365-71 [9273827.001]
  • [Cites] Epidemiology. 1997 Sep;8(5):551-8 [9270958.001]
  • [Cites] Transfusion. 1997 Oct;37(10):1084-92 [9354830.001]
  • [Cites] Int J Cancer. 1997 Sep 17;72(6):923-30 [9378552.001]
  • [Cites] Leuk Res. 1997 Sep;21(9):885-8 [9393604.001]
  • [Cites] Int J Cancer. 1997 Nov 27;73(5):645-50 [9398040.001]
  • [Cites] Cancer Causes Control. 1998 Jan;9(1):49-56 [9486463.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):621-5 [9681531.001]
  • [Cites] Am J Surg Pathol. 1998 Oct;22(10):1184-91 [9777980.001]
  • [Cites] Ann Oncol. 1998 Aug;9(8):849-55 [9789607.001]
  • [Cites] Haematologica. 2001 Jan;86(1):58-63 [11146572.001]
  • (PMID = 16394280.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1860250
  •  go-up   go-down


42. Cauwelier B, Dastugue N, Cools J, Poppe B, Herens C, De Paepe A, Hagemeijer A, Speleman F: Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRbeta locus rearrangements and putative new T-cell oncogenes. Leukemia; 2006 Jul;20(7):1238-44

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Therefore, we initiated a screening of 126 T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma cases and 19 T-ALL cell lines using FISH break-apart assays for the different TCR loci.
  • [MeSH-major] Gene Rearrangement, T-Lymphocyte / genetics. Genes, T-Cell Receptor beta / genetics. Leukemia-Lymphoma, Adult T-Cell / epidemiology. Leukemia-Lymphoma, Adult T-Cell / genetics
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Female. Genes, T-Cell Receptor alpha / genetics. Genes, T-Cell Receptor delta / genetics. Humans. In Situ Hybridization, Fluorescence. Incidence. Male. Middle Aged. Retrospective Studies. Translocation, Genetic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16673021.001).
  • [ISSN] 0887-6924
  • [Journal-full-title] Leukemia
  • [ISO-abbreviation] Leukemia
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


43. D'Souza S, Duncan A, Aguila F, Oderich G, Ricotta J, Kalra M, Gloviczki P, Bower T, Sundt T: TEVAR for non-aneurysmal thoracic aortic pathology. Catheter Cardiovasc Interv; 2009 Nov 1;74(5):783-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] TEVAR for non-aneurysmal thoracic aortic pathology.
  • OBJECTIVE: Management of penetrating atherosclerotic ulcers (PAU), intramural hematomas (IMH), and acute aortic dissections (AD) of the thoracic aorta remain controversial in the endovascular era.
  • CONCLUSION: TEVAR is a feasible option for repair of non-aneurysmal thoracic aortic pathology with resolution of symptoms, no mortality, and no neurologic complications.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Aortic Rupture / surgery. Aortography / methods. Blood Vessel Prosthesis. Female. Hematoma / surgery. Humans. Length of Stay. Male. Middle Aged. Prosthesis Design. Prosthesis Failure. Reoperation. Time Factors. Tomography, X-Ray Computed. Treatment Outcome. Ulcer / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Wiley-Liss, Inc.
  • (PMID = 19496139.001).
  • [ISSN] 1522-726X
  • [Journal-full-title] Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • [ISO-abbreviation] Catheter Cardiovasc Interv
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, Yap P, Fevery J, Roskams T, Pirenne J, Nevens F: MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int; 2007 Apr;27(3):329-34
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure.
  • AIMS/BACKGROUND: A model for end stage liver disease (MELD) score >30 was proposed as an excellent predictor of mortality in patients with non-acetaminophen-induced acute liver failure (ALF).
  • CONCLUSIONS: MELD score, which mostly takes into consideration the degree of liver impairment, has a similar prognostic value as King's College Hospital criteria to predict outcome in adult patients with nonacetaminophen-induced ALF.
  • [MeSH-major] Liver Failure, Acute / mortality
  • [MeSH-minor] Adult. Female. Humans. Liver Transplantation. Male. Middle Aged. Models, Biological. Prognosis. Sensitivity and Specificity. Survival Rate. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17355453.001).
  • [ISSN] 1478-3223
  • [Journal-full-title] Liver international : official journal of the International Association for the Study of the Liver
  • [ISO-abbreviation] Liver Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


45. Kawai A, Umeda T, Wada T, Ihara K, Isu K, Abe S, Ishii T, Sugiura H, Araki N, Ozaki T, Yabe H, Hasegawa T, Tsugane S, Beppu Y, JMOG Group: Alternating sequential chemotherapy with high-dose ifosfamide and doxorubicin/cyclophosphamide for adult non-small round cell soft tissue sarcomas. J Orthop Sci; 2005 May;10(3):258-63
Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alternating sequential chemotherapy with high-dose ifosfamide and doxorubicin/cyclophosphamide for adult non-small round cell soft tissue sarcomas.
  • We therefore conducted a Phase II trial to investigate the efficacy and feasibility of a novel alternating sequential chemotherapy regimen consisting of high dose ifosfamide and doxorubicin/cyclophosphamide in advanced adult non-small round cell soft tissue sarcomas.
  • Adult patients with non-small round cell soft tissue sarcomas were enrolled.
  • Sequential administration of high-dose ifosfamide and doxorubicin/cyclophosphamide has promising activity with manageable side effects in patients with advanced adult non-small round cell soft tissue sarcomas.
  • [MeSH-minor] Adult. Aged. Cyclophosphamide / administration & dosage. Cyclophosphamide / adverse effects. Doxorubicin / administration & dosage. Doxorubicin / adverse effects. Female. Humans. Ifosfamide / administration & dosage. Ifosfamide / adverse effects. Male. Middle Aged. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15928887.001).
  • [ISSN] 0949-2658
  • [Journal-full-title] Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
  • [ISO-abbreviation] J Orthop Sci
  • [Language] eng
  • [Publication-type] Clinical Trial; Clinical Trial, Phase II; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


46. Hori T, Suzuki N, Mizue N, Hatakeyama N, Takamuro M, Tsutsumi H: Relapse of T-cell all after stem cell transplant presenting as hypertrophic cardiomyopathy: the value of non-invasive diagnostic imaging in detecting cardiac leukemia. Pediatr Blood Cancer; 2006 Jan;46(1):108-11
MedlinePlus Health Information. consumer health - Diagnostic Imaging.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Relapse of T-cell all after stem cell transplant presenting as hypertrophic cardiomyopathy: the value of non-invasive diagnostic imaging in detecting cardiac leukemia.
  • We describe a 14-year-old female with acute lymphoblastic leukemia (ALL) with a mediastinal mass at diagnosis who developed hypertrophic cardiomyopathy (HC) after stem cell transplantation (SCT).
  • However, isolated cardiac relapse was finally diagnosed by several non-invasive imaging techniques.
  • [MeSH-major] Cardiomyopathy, Hypertrophic / etiology. Diagnostic Imaging. Leukemia-Lymphoma, Adult T-Cell / pathology. Leukemic Infiltration. Myocardium / pathology

  • Genetic Alliance. consumer health - Cardiomyopathy.
  • Genetic Alliance. consumer health - Hypertrophic Cardiomyopathy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16078227.001).
  • [ISSN] 1545-5009
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


47. Monsalve-Castillo F, Echevarría JM, Atencio R, Suárez A, Estévez J, Costa-León L, Montiel P, Molero T, Zambrano M: [High prevalence of hepatitis B infection in Amerindians in Japreira, Zulia State, Venezuela]. Cad Saude Publica; 2008 May;24(5):1183-6
MedlinePlus Health Information. consumer health - Hepatitis B.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An intentional, non-probabilistic sample of 149 individuals was selected from a total of 300.
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Chi-Square Distribution. Child. Child, Preschool. Female. Hepatitis B Antibodies / blood. Hepatitis B Surface Antigens / blood. Humans. Male. Middle Aged. Prevalence. Sex Distribution. Venezuela / epidemiology. Venezuela / ethnology

  • Genetic Alliance. consumer health - Hepatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18461250.001).
  • [ISSN] 0102-311X
  • [Journal-full-title] Cadernos de saúde pública
  • [ISO-abbreviation] Cad Saude Publica
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Hepatitis B Antibodies; 0 / Hepatitis B Surface Antigens
  •  go-up   go-down


48. Bairey O, Ruchlemer R, Shpilberg O: Non-Hodgkin's lymphomas of the colon. Isr Med Assoc J; 2006 Dec;8(12):832-5
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-Hodgkin's lymphomas of the colon.
  • BACKGROUND: Non-Hodgkin's lymphoma of the colon is a rare and consequently poorly studied extranodal lymphoma.
  • Three patients had mantle cell lymphoma and two had indolent lymphomas: mucosa-associated lymphoid tissue (n=l) and small lymphocytic (n=l).
  • [MeSH-major] Colorectal Neoplasms / diagnosis. Lymphoma, Non-Hodgkin / diagnosis. Treatment Outcome
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Disease Progression. Female. Humans. Male. Middle Aged. Prognosis. Registries. Remission Induction. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17214096.001).
  • [ISSN] 1565-1088
  • [Journal-full-title] The Israel Medical Association journal : IMAJ
  • [ISO-abbreviation] Isr. Med. Assoc. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Israel
  •  go-up   go-down


49. Dik WA, Brahim W, Braun C, Asnafi V, Dastugue N, Bernard OA, van Dongen JJ, Langerak AW, Macintyre EA, Delabesse E: CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia; 2005 Nov;19(11):1948-57
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The t(10;11)(p13;q14-21) is found in T-ALL and acute myeloid leukemia and fuses CALM (Clathrin-Assembly protein-like Lymphoid-Myeloid leukaemia gene) to AF10.
  • Microarray results were validated by quantitative RT-PCR on an independent group of T-ALL and compared to mixed lineage leukemia-translocated acute leukemias (MLL-t AL).
  • We propose to define a HOXA+ leukemia group composed of at least MLL-t, CALM-AF10 and HOXA-t AL, which may benefit from adapted management.
  • [MeSH-major] Homeodomain Proteins / biosynthesis. Leukemia-Lymphoma, Adult T-Cell / genetics. Leukemia-Lymphoma, Adult T-Cell / physiopathology. Nuclear Proteins / biosynthesis. Oncogene Proteins, Fusion / biosynthesis. Proto-Oncogene Proteins / biosynthesis. Repressor Proteins / biosynthesis
  • [MeSH-minor] Adolescent. Adult. Cell Proliferation. Cell Transformation, Neoplastic. Child. Gene Expression Profiling. Humans. Oligonucleotide Array Sequence Analysis. Polycomb Repressive Complex 1. Reverse Transcriptase Polymerase Chain Reaction. Transcription, Genetic. Up-Regulation

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16107895.001).
  • [ISSN] 0887-6924
  • [Journal-full-title] Leukemia
  • [ISO-abbreviation] Leukemia
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / AF10-CALM fusion protein, human; 0 / BMI1 protein, human; 0 / Homeodomain Proteins; 0 / Nuclear Proteins; 0 / Oncogene Proteins, Fusion; 0 / Proto-Oncogene Proteins; 0 / Repressor Proteins; 157907-48-7 / HoxA protein; EC 6.3.2.19 / Polycomb Repressive Complex 1
  •  go-up   go-down


50. Quintana-Murci L, Gal I, Bakhan T, Quach H, Sayar SH, Shiri-Sverdlov R, Baruch RG, McElreavey K, Dagan E, Narod S, Friedman E: The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews. Fam Cancer; 2005;4(2):85-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews.
  • BACKGROUND: The Tyr978X BRCA1 mutation is a founder mutation detected in high-risk Iraqi-Iranian Jewish families as well as in the general non-Ashkenazi population.
  • The same mutation was also reported in non-Jewish high-risk women from Canada.
  • Its occurrence in non-Jewish individuals from Iran has never been tested.
  • OBJECTIVE: Assess the occurrence rate of Tyr978X BRCA1 germline mutation in the general population of Iranian non- Jewish individuals and compare the BRCA1-linked haplotype of Jewish and non-Jewish mutation carriers.
  • The tested population included 442 apparently healthy Iranian non-Jewish individuals, and 17 mutation carriers from Israel and Canada.
  • RESULTS: The Tyr978X BRCA1 mutation was not detected in any Iranian non-Jewish individual.
  • The intragenic haplotype of all Jewish Israeli mutation carriers was identical, but differed from that of Canadian non-Jews in two intragenic markers.
  • CONCLUSIONS: The Tyr978X BRCA1 mutation which is a founder mutation in Jews, may be a hot spot in non-Jewish high risk women, and probably does not represent a rare sequence variant in Iranian non-Jews.
  • [MeSH-minor] Adult. Aged. Breast Neoplasms / genetics. Canada / epidemiology. DNA Mutational Analysis. Female. France / ethnology. Haplotypes. Heterozygote. Humans. Incidence. Iran / epidemiology. Israel / epidemiology. Male. Middle Aged. Ovarian Neoplasms / genetics. Risk Factors

  • MedlinePlus Health Information. consumer health - Genetic Testing.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Genet. 1995 Oct;11(2):198-200 [7550349.001]
  • [Cites] Am J Hum Genet. 1998 Mar;62(3):676-89 [9497246.001]
  • [Cites] Am J Hum Genet. 1998 Jun;62(6):1381-8 [9585613.001]
  • [Cites] N Engl J Med. 2001 Jul 26;345(4):235-40 [11474660.001]
  • [Cites] Br J Cancer. 1998 Jun;77(11):1880-3 [9667663.001]
  • [Cites] Hum Hered. 2001;52(2):116-20 [11512557.001]
  • [Cites] Am J Hum Genet. 1996 Feb;58(2):271-80 [8571953.001]
  • [Cites] Eur J Hum Genet. 2001 Oct;9(10):773-9 [11781689.001]
  • [Cites] Cancer Lett. 2001 Apr 10;165(1):87-94 [11248423.001]
  • [Cites] Community Genet. 2001 Jul;4(1):50-55 [11493753.001]
  • [Cites] Am J Hum Genet. 2001 Feb;68(2):537-42 [11133362.001]
  • [Cites] Nat Genet. 1996 Oct;14(2):188-90 [8841192.001]
  • [Cites] Hum Mol Genet. 1998 May;7(5):801-5 [9536083.001]
  • [Cites] Eur J Hum Genet. 1997 Nov-Dec;5(6):413-6 [9450187.001]
  • [Cites] Cancer Genet Cytogenet. 1999 Mar;109(2):91-8 [10087939.001]
  • [Cites] Am J Hum Genet. 2001 Mar;68(3):700-10 [11179017.001]
  • [Cites] Am J Hum Genet. 1999 Apr;64(4):963-70 [10090881.001]
  • [Cites] Am J Hum Genet. 1997 Mar;60(3):505-14 [9042909.001]
  • [Cites] Am J Hum Genet. 1996 Jun;58(6):1166-76 [8651293.001]
  • [Cites] Am J Hum Genet. 1997 May;60(5):1013-20 [9150148.001]
  • [Cites] Lancet. 1994 Mar 19;343(8899):692-5 [7907678.001]
  • (PMID = 15951957.001).
  • [ISSN] 1389-9600
  • [Journal-full-title] Familial cancer
  • [ISO-abbreviation] Fam. Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


51. Sulis ML, Williams O, Palomero T, Tosello V, Pallikuppam S, Real PJ, Barnes K, Zuurbier L, Meijerink JP, Ferrando AA: NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. Blood; 2008 Aug 1;112(3):733-40
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Heterodimerization domain (HD) mutations in NOTCH1 induce ligand-independent activation of the receptor and contribute to the pathogenesis of one-third of human T-cell lymphoblastic leukemias (T-ALLs).
  • Notably, structure-function analysis of leukemia-derived and synthetic JME mutants demonstrated that the aberrant activation of NOTCH1 signaling is dependent on the number of residues introduced in the extracellular juxtamembrane region of the receptor and not on the specific amino acid sequence of these insertions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Opin Immunol. 2000 Apr;12(2):166-72 [10712939.001]
  • [Cites] Annu Rev Pathol. 2008;3:587-613 [18039126.001]
  • [Cites] Mol Cell. 2000 Feb;5(2):197-206 [10882062.001]
  • [Cites] Mol Cell. 2000 Feb;5(2):207-16 [10882063.001]
  • [Cites] Immunity. 2001 Mar;14(3):253-64 [11290335.001]
  • [Cites] J Exp Med. 2001 Oct 1;194(7):991-1002 [11581320.001]
  • [Cites] Immunity. 2002 Jun;16(6):869-79 [12121668.001]
  • [Cites] J Immunol. 2002 Aug 15;169(4):1817-21 [12165504.001]
  • [Cites] Cancer Cell. 2003 Mar;3(3):203-5 [12676578.001]
  • [Cites] Semin Immunol. 2003 Apr;15(2):69-79 [12681943.001]
  • [Cites] J Exp Med. 2004 Aug 16;200(4):469-79 [15314075.001]
  • [Cites] Science. 2004 Oct 8;306(5694):269-71 [15472075.001]
  • [Cites] Cell. 1991 Aug 23;66(4):649-61 [1831692.001]
  • [Cites] Cell. 1996 Nov 1;87(3):483-92 [8898201.001]
  • [Cites] Cell. 1997 Mar 21;88(6):833-43 [9118226.001]
  • [Cites] Development. 1997 Dec;124(23):4759-67 [9428412.001]
  • [Cites] Genes Dev. 1998 Jun 15;12(12):1751-62 [9637676.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8108-12 [9653148.001]
  • [Cites] Science. 1999 Jan 1;283(5398):91-4 [9872749.001]
  • [Cites] Nature. 1999 Apr 8;398(6727):522-5 [10206646.001]
  • [Cites] Immunity. 1999 May;10(5):547-58 [10367900.001]
  • [Cites] Immunity. 1999 Sep;11(3):299-308 [10514008.001]
  • [Cites] Nat Immunol. 2005 Mar;6(3):314-22 [15665828.001]
  • [Cites] Cell. 2005 Aug 12;122(3):435-47 [16096062.001]
  • [Cites] Nat Rev Cancer. 2006 May;6(5):347-59 [16612405.001]
  • [Cites] Mol Cell Biol. 2006 Jun;26(12):4642-51 [16738328.001]
  • [Cites] Leukemia. 2006 Jul;20(7):1279-87 [16688224.001]
  • [Cites] Blood. 2006 Aug 15;108(4):1151-7 [16614245.001]
  • [Cites] Nat Struct Mol Biol. 2007 Apr;14(4):295-300 [17401372.001]
  • [Cites] J Exp Med. 2007 Aug 6;204(8):1825-35 [17646408.001]
  • [Cites] Nucleic Acids Res. 2008 Jan;36(Database issue):D25-30 [18073190.001]
  • [CommentIn] Blood. 2008 Aug 1;112(3):457-8 [18650457.001]
  • (PMID = 18411416.001).
  • [ISSN] 1528-0020
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA120196-03; United States / NCI NIH HHS / CA / R01 CA120196; United States / NCI NIH HHS / CA / CA120196; United States / NCI NIH HHS / CA / R01 CA120196-03
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptor, Notch1; EC 3.4.- / Amyloid Precursor Protein Secretases
  • [Other-IDs] NLM/ PMC2481531
  •  go-up   go-down


52. Chatti Dey S, Ben Brahim E, Ezzine H, Essid M, Baba T, Azzouz M: [Nonalcoholic steatohepatitis: epidemiologic and pathologic study of 9 cases]. Tunis Med; 2008 Jan;86(1):6-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] La stéatohépatite non alcoolique etude anatomoclinique de 9 observations.
  • BACKGROUND: Non alcohol steatohepatitis is an acquired chronic hepatopathy frequently of metabolic origin.
  • METHODS: 9 cases of non alcohol steatohepatitis are diagnosed in our hospital in 3 years between 2001 to 2004.
  • [MeSH-minor] Adult. Age Distribution. Female. Fibrosis. Humans. Liver / pathology. Male. Middle Aged. Retrospective Studies. Sex Distribution. Tunisia / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19472691.001).
  • [ISSN] 0041-4131
  • [Journal-full-title] La Tunisie médicale
  • [ISO-abbreviation] Tunis Med
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Tunisia
  •  go-up   go-down


53. Weihrauch MR, von Bergwelt-Baildon M, Kandic M, Weskott M, Klamp W, Rosler J, Schultze JL: T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals. World J Gastroenterol; 2008 Apr 28;14(16):2529-33
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals.
  • AIM: To evaluate, whether humoral hepatitis-B-vaccine non-responders also fail to mount a T cell response and to compare these results to normal vaccinees.
  • METHODS: Fourty-seven health care employees were enrolled in this study including all available non-responders (n = 13) with an anti-HBsAg titer < 10 kU/L and all available low-responders (n = 12) with an anti-HBsAg titer < 100 kU/L.
  • RESULTS: Non-responders and low-responders had no or only very limited T cell responses, respectively.
  • CONCLUSION: Our data suggest that there is no general immune deficiency in non-/low-responders.
  • [MeSH-minor] Adult. Carrier State / epidemiology. Female. Global Health. Hepatitis B / epidemiology. Hepatitis B / immunology. Humans. Leukocytes, Mononuclear / cytology. Leukocytes, Mononuclear / immunology. Male. Middle Aged. Prevalence. Young Adult

  • Genetic Alliance. consumer health - Hepatitis.
  • MedlinePlus Health Information. consumer health - Cirrhosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 1997 Jun 26;336(26):1855-9 [9197213.001]
  • [Cites] N Engl J Med. 1997 Jan 16;336(3):196-204 [8988900.001]
  • [Cites] Hum Immunol. 1997 Nov;58(1):42-51 [9438208.001]
  • [Cites] Vaccine. 1998 Apr;16(7):708-14 [9562690.001]
  • [Cites] Hum Immunol. 1998 Apr;59(4):212-8 [9568796.001]
  • [Cites] Tissue Antigens. 1998 Jun;51(6):593-604 [9694351.001]
  • [Cites] Tissue Antigens. 1998 Oct;52(4):374-80 [9820601.001]
  • [Cites] Hepatology. 1999 Jan;29(1):238-44 [9862872.001]
  • [Cites] J Clin Immunol. 2004 Nov;24(6):693-701 [15622454.001]
  • [Cites] Clin Exp Immunol. 2005 Apr;140(1):126-37 [15762884.001]
  • [Cites] Vaccine. 2006 Jan 30;24(5):572-7 [16171909.001]
  • [Cites] Hepatology. 2000 Feb;31(2):521-7 [10655280.001]
  • [Cites] Vaccine. 2000 Apr 14;18(20):2095-101 [10715523.001]
  • [Cites] Scand J Immunol. 2002 Mar;55(3):311-4 [11940238.001]
  • [Cites] J Hepatol. 2002 Sep;37(3):387-92 [12175635.001]
  • [Cites] Vaccine. 2004 Sep 9;22(27-28):3789-96 [15315860.001]
  • [Cites] N Engl J Med. 1980 Oct 9;303(15):833-41 [6997738.001]
  • [Cites] N Engl J Med. 1982 Dec 9;307(24):1481-6 [6755247.001]
  • [Cites] Ann Intern Med. 1984 Jul;101(1):34-40 [6233921.001]
  • [Cites] Ann Intern Med. 1986 Sep;105(3):356-60 [2943202.001]
  • [Cites] Immunology. 1988 Jul;64(3):545-50 [3261712.001]
  • [Cites] JAMA. 1988 Sep 23-30;260(12):1734-8 [2970557.001]
  • [Cites] N Engl J Med. 1989 Sep 14;321(11):708-12 [2528067.001]
  • [Cites] Am J Med. 1989 Sep 4;87(3A):30S-32S [2528295.001]
  • [Cites] Am J Med. 1989 Sep 4;87(3A):36S-40S [2528297.001]
  • [Cites] JAMA. 1990 Jul 11;264(2):181-2 [2141364.001]
  • [Cites] Immunology. 1990 Jun;70(2):197-202 [2115499.001]
  • [Cites] Tissue Antigens. 1990 Aug;36(2):69-74 [1702907.001]
  • [Cites] Semin Liver Dis. 1991 May;11(2):165-74 [1716004.001]
  • [Cites] Scand J Immunol. 1991 Oct;34(4):433-44 [1718026.001]
  • [Cites] Nephron. 1992;61(3):352-3 [1386909.001]
  • [Cites] Immunol Lett. 1994 Feb;39(2):163-8 [8013962.001]
  • [Cites] J Immunol. 1995 Jan 15;154(2):520-9 [7814865.001]
  • [Cites] Immunogenetics. 1995;41(6):366-74 [7759133.001]
  • [Cites] Vaccine. 1995;13 Suppl 1:S47-9 [7571830.001]
  • [Cites] Vaccine. 1997 Oct;15(15):1618-23 [9364692.001]
  • (PMID = 18442200.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Hepatitis B Surface Antigens; 0 / Hepatitis B Vaccines
  • [Other-IDs] NLM/ PMC2708364
  •  go-up   go-down


54. Shi YX, Peng RJ, Lin SX, Wu QL, Lin TY, Sun XF, Huang HQ, Xia ZJ, Li YH, Xu RH, Liu DG, Guan ZZ, Jiang WQ: [A survival of 103 cases of T-cell non-Hodgkin lymphoma]. Zhonghua Nei Ke Za Zhi; 2007 Dec;46(12):1000-2
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A survival of 103 cases of T-cell non-Hodgkin lymphoma].
  • OBJECTIVE: T-cell non-Hodgkin lymphoma was heterogeneous and relatively high incident in our country.
  • [MeSH-major] Lymphoma, Non-Hodgkin / therapy. Lymphoma, T-Cell / therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Combined Modality Therapy. Drug Therapy. Female. Humans. Male. Middle Aged. Neoplasm Staging. Prognosis. Radiotherapy. Retrospective Studies. Stem Cell Transplantation. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Hodgkin lymphoma.
  • Genetic Alliance. consumer health - Non-Hodgkin Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18478916.001).
  • [ISSN] 0578-1426
  • [Journal-full-title] Zhonghua nei ke za zhi
  • [ISO-abbreviation] Zhonghua Nei Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


55. Gierok SD, Dickson AL, Cole JA: Performance of forensic and non-forensic adult psychiatric inpatients on the Test of Memory Malingering. Arch Clin Neuropsychol; 2005 Aug;20(6):755-60
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Performance of forensic and non-forensic adult psychiatric inpatients on the Test of Memory Malingering.
  • New York: Multi Health Systems]) between a Forensic Psychiatric group and a Non-forensic Psychiatric group of 20 men each.
  • [MeSH-minor] Adult. Humans. Male. Neuropsychological Tests / statistics & numerical data. Psychiatric Status Rating Scales

  • MedlinePlus Health Information. consumer health - Memory.
  • MedlinePlus Health Information. consumer health - Mental Disorders.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15894456.001).
  • [ISSN] 0887-6177
  • [Journal-full-title] Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
  • [ISO-abbreviation] Arch Clin Neuropsychol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Aschim EL, Haugen TB, Tretli S, Daltveit AK, Grotmol T: Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma? Int J Androl; 2006 Aug;29(4):458-67
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?
  • Clinically, TGCCs are divided into two major histological groups, seminomas and non-seminomas, where the latter group includes non-seminomatous TGCCs with seminomatous components (mixed S/NS TGCC).
  • Recent studies, however, have suggested that non-seminomas and mixed S/NS TGCCs could have certain differences in aetiology, and in this study the TGCCs were divided into three, rather than the conventional two histological groups.
  • Several of the variables studied seemed to be risk factors for specific histological groups, e.g. parity 0 vs. 2 and low gestational age being associated with increased risk of non-seminomas, but not of mixed S/NS TGCC, and low maternal age being associated with increased risk of mixed S/NS TGCC, but not of non-seminomatous TGCC.
  • Therefore, our results might suggest that non-seminomas and mixed S/NS TGCCs have partially different risk factors, whose associations may be obscured by combining these two histological groups.
  • [MeSH-minor] Adolescent. Adult. Child. Cohort Studies. Female. Gestational Age. Humans. Infant. Male. Maternal Welfare. Norway / epidemiology. Parity. Pregnancy. Registries. Risk Factors


57. Colovic N, Jurisic V, Terzic T, Atkinson HD, Colovic M: Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma. Arch Dermatol Res; 2009 Oct;301(9):689-92
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
  • The case of a 44-year-old man with a primary cutaneous large B-cell non-Hodgkin's lymphoma of the scalp is reported.
  • The histopathology and immunohistochemistry performed in April 2006 indicated a bcl-6+, MUM- and bcl-2-, primary cutaneous follicle center B-cell non-Hodgkin's lymphoma, with an aggressive transformation to a diffuse large B-cell lymphoma.
  • [MeSH-minor] Adult. Antibodies, Monoclonal, Murine-Derived. Antigens, Neoplasm / metabolism. Cyclophosphamide / therapeutic use. Doxorubicin / therapeutic use. Humans. Immunotherapy. Injections, Intravenous. Male. Prednisone / therapeutic use. Proto-Oncogene Proteins c-bcl-2 / metabolism. Rituximab. Treatment Outcome. Vesicular Transport Proteins / metabolism. Vincristine / therapeutic use

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. RITUXIMAB .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19495780.001).
  • [ISSN] 1432-069X
  • [Journal-full-title] Archives of dermatological research
  • [ISO-abbreviation] Arch. Dermatol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Antigens, Neoplasm; 0 / Antineoplastic Agents; 0 / BCL2L15 protein, human; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / TRAPPC1 protein, human; 0 / Vesicular Transport Proteins; 4F4X42SYQ6 / Rituximab; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


58. Collins JA, Hernández AV, Hidalgo JA, Villena J, Sumire J, Delgado V, Salazar R, Almenara Hospital AIDS Working Group: High proportion of T-cell systemic non-Hodgkin lymphoma in HIV-infected patients in Lima, Peru. J Acquir Immune Defic Syndr; 2005 Dec 15;40(5):558-64
MedlinePlus Health Information. consumer health - HIV/AIDS in Women.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High proportion of T-cell systemic non-Hodgkin lymphoma in HIV-infected patients in Lima, Peru.
  • OBJECTIVE: Few reports have described the clinical and pathologic characteristics of HIV-related systemic non-Hodgkin lymphoma (sNHL) in developing countries.
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Multivariate Analysis. Peru / epidemiology. Phenotype


59. Li X, Gounari F, Protopopov A, Khazaie K, von Boehmer H: Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J Exp Med; 2008 Nov 24;205(12):2851-61
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mutations resulting in overexpression of intracellular Notch1 (ICN1) are frequently observed in human T cell acute lymphoblastic leukemia (T-ALL).

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 2007 Jun 21;447(7147):966-71 [17515920.001]
  • [Cites] Nature. 1985 Mar 7-13;314(6006):103-7 [2983227.001]
  • [Cites] J Exp Med. 2007 Aug 6;204(8):1813-24 [17646409.001]
  • [Cites] Cell. 2007 Jun 1;129(5):879-90 [17540169.001]
  • [Cites] Genes Dev. 1999 Oct 15;13(20):2658-69 [10541552.001]
  • [Cites] Genes Dev. 1999 Oct 15;13(20):2678-90 [10541554.001]
  • [Cites] Blood. 2000 Mar 15;95(6):2104-10 [10706881.001]
  • [Cites] Immunity. 2001 Jan;14(1):45-55 [11163229.001]
  • [Cites] Nat Immunol. 2001 Mar;2(3):235-41 [11224523.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3788-93 [11891328.001]
  • [Cites] Nat Immunol. 2002 May;3(5):483-8 [11927911.001]
  • [Cites] Nature. 1985 May 16-22;315(6016):232-3 [3873615.001]
  • [Cites] Cell. 1991 Aug 9;66(3):533-40 [1868548.001]
  • [Cites] Nature. 1995 Jun 29;375(6534):795-8 [7596413.001]
  • [Cites] Genes Dev. 1996 Aug 1;10(15):1930-44 [8756350.001]
  • [Cites] Annu Rev Immunol. 1997;15:433-52 [9143695.001]
  • [Cites] Mol Cell Biol. 1997 Aug;17(8):4782-91 [9234734.001]
  • [Cites] Science. 1999 Apr 30;284(5415):770-6 [10221902.001]
  • [Cites] Mol Cell. 1999 Aug;4(2):199-207 [10488335.001]
  • [Cites] Curr Opin Hematol. 2004 Nov;11(6):426-33 [15548998.001]
  • [Cites] Nat Rev Immunol. 2005 Jun;5(6):497-508 [15928681.001]
  • [Cites] Nat Rev Mol Cell Biol. 2005 Aug;6(8):635-45 [16064138.001]
  • [Cites] Nat Immunol. 2005 Sep;6(9):881-8 [16056227.001]
  • [Cites] J Exp Med. 2006 May 15;203(5):1329-42 [16682500.001]
  • [Cites] Blood. 2006 Jul 1;108(1):305-10 [16507772.001]
  • [Cites] Genes Dev. 2006 Aug 1;20(15):2096-109 [16847353.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18261-6 [17114293.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6274-9 [11983916.001]
  • [Cites] Cancer Cell. 2002 Feb;1(1):75-87 [12086890.001]
  • [Cites] Cancer Cell. 2002 Mar;1(2):133-43 [12086872.001]
  • [Cites] Cell. 2002 Jun 28;109(7):811-21 [12110179.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11322-7 [12172006.001]
  • [Cites] Mol Cell Biol. 2003 Jan;23(2):655-64 [12509463.001]
  • [Cites] Blood. 2003 Apr 1;101(7):2797-803 [12517816.001]
  • [Cites] EMBO J. 2003 Nov 3;22(21):5780-92 [14592976.001]
  • [Cites] EMBO Rep. 2003 Nov;4(11):1067-72 [14566327.001]
  • [Cites] Cancer Cell. 2003 Dec;4(6):451-61 [14706337.001]
  • [Cites] Blood. 2004 Sep 15;104(6):1696-702 [15187027.001]
  • [Cites] Science. 2004 Oct 8;306(5694):269-71 [15472075.001]
  • [Cites] J Exp Med. 2007 Aug 6;204(8):1825-35 [17646408.001]
  • (PMID = 18981238.001).
  • [ISSN] 1540-9538
  • [Journal-full-title] The Journal of experimental medicine
  • [ISO-abbreviation] J. Exp. Med.
  • [Language] ENG
  • [Databank-accession-numbers] GEO/ GSE12948
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI045846; United States / NCI NIH HHS / CA / P01 CA109901; United States / NCI NIH HHS / CA / T32 CA070083; United States / NCI NIH HHS / CA / T32-CA70083; United States / NIAID NIH HHS / AI / R01 AI45846; United States / NCI NIH HHS / CA / CA109901
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Notch1 protein, mouse; 0 / Proto-Oncogene Proteins c-myc; 0 / Receptor, Notch1; 0 / Receptors, Antigen, T-Cell, alpha-beta; 0 / Tumor Suppressor Protein p53
  • [Other-IDs] NLM/ PMC2585834
  •  go-up   go-down


60. Chagas AL, Kikuchi LO, Oliveira CP, Vezozzo DC, Mello ES, Oliveira AC, Cella LC, Herman P, Bachella T, Caldwell SH, Alves VA, Carrilho FJ: Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients? Braz J Med Biol Res; 2009 Oct;42(10):958-62
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
  • Non-alcoholic steatohepatitis (NASH) has been associated with hepatocellular carcinoma (HCC) often arising in histologically advanced disease when steatohepatitis is not active (cryptogenic cirrhosis).
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Cirrhosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19787150.001).
  • [ISSN] 1414-431X
  • [Journal-full-title] Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
  • [ISO-abbreviation] Braz. J. Med. Biol. Res.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / P30 DK067629
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


61. O'Neil J, Calvo J, McKenna K, Krishnamoorthy V, Aster JC, Bassing CH, Alt FW, Kelliher M, Look AT: Activating Notch1 mutations in mouse models of T-ALL. Blood; 2006 Jan 15;107(2):781-5
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recent studies have demonstrated that most patients with T-cell acute lymphocytic leukemia (T-ALL) have activating mutations in NOTCH1.
  • We sequenced the heterodimerization domain and the PEST domain of Notch1 in our mouse model of TAL1-induced leukemia and found that 74% of the tumors harbor activating mutations in Notch1.
  • [MeSH-major] Disease Models, Animal. Leukemia-Lymphoma, Adult T-Cell / genetics. Lymphoma / genetics. Mutation / genetics. Receptor, Notch1 / genetics. Thymus Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Lymphoma.
  • MedlinePlus Health Information. consumer health - Thymus Cancer.
  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Cell Biol. 2000 Jun;20(11):3831-42 [10805726.001]
  • [Cites] Oncogene. 2006 May 18;25(21):3023-31 [16407836.001]
  • [Cites] Immunity. 2000 Jul;13(1):73-84 [10933396.001]
  • [Cites] Blood. 2000 Sep 1;96(5):1906-13 [10961893.001]
  • [Cites] J Virol. 2000 Oct;74(20):9786-91 [11000255.001]
  • [Cites] Semin Hematol. 2000 Oct;37(4):381-95 [11071360.001]
  • [Cites] Blood. 2001 Mar 1;97(5):1211-8 [11222362.001]
  • [Cites] Science. 2002 May 3;296(5569):922-7 [11934988.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8173-8 [12034884.001]
  • [Cites] Cancer Cell. 2002 Feb;1(1):75-87 [12086890.001]
  • [Cites] Cell. 2003 Aug 8;114(3):359-70 [12914700.001]
  • [Cites] Cell. 2003 Aug 8;114(3):371-83 [12914701.001]
  • [Cites] Blood. 2003 Oct 1;102(7):2593-6 [12816868.001]
  • [Cites] Semin Hematol. 2003 Oct;40(4):274-80 [14582078.001]
  • [Cites] Blood. 2004 Mar 1;103(5):1909-11 [14604958.001]
  • [Cites] Lancet. 2004 Feb 14;363(9408):535-6 [14975618.001]
  • [Cites] Cancer Cell. 2004 Jun;5(6):587-96 [15193261.001]
  • [Cites] Science. 2004 Oct 8;306(5694):269-71 [15472075.001]
  • [Cites] Cell. 1992 Mar 6;68(5):855-67 [1547487.001]
  • [Cites] Cell. 1996 Apr 5;85(1):27-37 [8620534.001]
  • [Cites] EMBO J. 1996 Oct 1;15(19):5160-6 [8895560.001]
  • [Cites] Oncogene. 1998 Jan 29;16(4):517-22 [9484841.001]
  • [Cites] Science. 1999 Apr 30;284(5415):770-6 [10221902.001]
  • [Cites] Blood. 2000 Jun 1;95(11):3310-22 [10828010.001]
  • (PMID = 16166587.001).
  • [ISSN] 0006-4971
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA096899
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Basic Helix-Loop-Helix Transcription Factors; 0 / DNA-Binding Proteins; 0 / Enzyme Inhibitors; 0 / H2AX protein, mouse; 0 / Histones; 0 / NOTCH1 protein, human; 0 / Proto-Oncogene Proteins; 0 / Rag2 protein, mouse; 0 / Receptor, Notch1; 0 / Tal1 protein, mouse; 0 / Tumor Suppressor Protein p53; EC 3.4.- / Amyloid Precursor Protein Secretases; EC 3.4.- / Endopeptidases; EC 3.4.23.- / Aspartic Acid Endopeptidases; EC 3.4.23.46 / BACE1 protein, human; EC 3.4.23.46 / Bace1 protein, mouse
  • [Other-IDs] NLM/ PMC1895623
  •  go-up   go-down


62. O'Neil J, Tchinda J, Gutierrez A, Moreau L, Maser RS, Wong KK, Li W, McKenna K, Liu XS, Feng B, Neuberg D, Silverman L, DeAngelo DJ, Kutok JL, Rothstein R, DePinho RA, Chin L, Lee C, Look AT: Alu elements mediate MYB gene tandem duplication in human T-ALL. J Exp Med; 2007 Dec 24;204(13):3059-66
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recent studies have demonstrated that the MYB oncogene is frequently duplicated in human T cell acute lymphoblastic leukemia (T-ALL).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 2000 Oct 1;60(19):5323-8 [11034064.001]
  • [Cites] Nat Genet. 2007 May;39(5):593-5 [17435759.001]
  • [Cites] Nat Rev Genet. 2002 May;3(5):370-9 [11988762.001]
  • [Cites] Nat Genet. 2002 Sep;32(1):160-5 [12185367.001]
  • [Cites] EMBO J. 2003 Sep 1;22(17):4478-88 [12941699.001]
  • [Cites] Nat Immunol. 2004 Jul;5(7):721-9 [15195090.001]
  • [Cites] Cancer Res. 2004 Jul 15;64(14):4744-8 [15256441.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Nov;41(3):257-65 [15334549.001]
  • [Cites] Science. 2004 Oct 8;306(5694):269-71 [15472075.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14853-8 [15466706.001]
  • [Cites] Proc Natl Acad Sci U S A. 1982 Aug;79(15):4714-7 [6289315.001]
  • [Cites] Cell. 1982 Dec;31(2 Pt 1):453-63 [6297766.001]
  • [Cites] Proc Natl Acad Sci U S A. 1984 Jul;81(14):4534-8 [6589609.001]
  • [Cites] Mol Cell Biol. 1988 Feb;8(2):884-92 [2832742.001]
  • [Cites] Cancer Lett. 1990 Jun 30;52(1):57-62 [2354420.001]
  • [Cites] J Exp Med. 1991 Oct 1;174(4):867-73 [1680958.001]
  • [Cites] Oncogene. 1992 Dec;7(12):2519-23 [1461655.001]
  • [Cites] Leukemia. 1995 Nov;9(11):1812-7 [7475267.001]
  • [Cites] Oncogene. 1996 Nov 21;13(10):2205-12 [8950988.001]
  • [Cites] Science. 1997 Nov 7;278(5340):1059-64 [9353180.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2390-5 [9482895.001]
  • [Cites] Am J Hum Genet. 1999 Jan;64(1):300-2 [9915971.001]
  • [Cites] Genes Dev. 1999 May 1;13(9):1073-8 [10323859.001]
  • [Cites] Nature. 2007 Jun 21;447(7147):966-71 [17515920.001]
  • [Cites] Blood. 2007 Aug 15;110(4):1251-61 [17452517.001]
  • [Cites] Mol Genet Metab. 1999 Jul;67(3):183-93 [10381326.001]
  • [Cites] Genes Dev. 2005 Oct 1;19(19):2331-42 [16166372.001]
  • [Cites] Blood. 2006 Aug 1;108(3):896-903 [16597594.001]
  • [Cites] Genes Dev. 2006 Aug 1;20(15):2096-109 [16847353.001]
  • [Cites] DNA Repair (Amst). 2006 Sep 8;5(9-10):1065-74 [16815104.001]
  • [Cites] Mol Cell Biol. 2006 Nov;26(21):8022-31 [16954387.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18261-6 [17114293.001]
  • [Cites] EMBO J. 2000 Nov 15;19(22):6112-20 [11080157.001]
  • (PMID = 18070937.001).
  • [ISSN] 1540-9538
  • [Journal-full-title] The Journal of experimental medicine
  • [ISO-abbreviation] J. Exp. Med.
  • [Language] ENG
  • [Databank-accession-numbers] GEO/ GSE7615
  • [Grant] United States / NCI NIH HHS / CA / P01 CA109901; United States / NIGMS NIH HHS / GM / R37 GM050237; United States / NCI NIH HHS / CA / CA11560; United States / NIGMS NIH HHS / GM / GM067055; United States / NIGMS NIH HHS / GM / R01 GM067055; United States / NIGMS NIH HHS / GM / R01 GM050237; United States / NCI NIH HHS / CA / R01 CA111560; United States / NCI NIH HHS / CA / R21 CA115853; United States / NIGMS NIH HHS / GM / GM050237; United States / NCI NIH HHS / CA / CA115853; United States / NCI NIH HHS / CA / CA68484-11; United States / NCI NIH HHS / CA / P01 CA068484; United States / NCI NIH HHS / CA / CA109901
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proto-Oncogene Proteins c-myb
  • [Other-IDs] NLM/ PMC2150982
  •  go-up   go-down


63. Huang L, Lequin M, Pieters R, van den Heuvel-Eibrink MM: The clinical value of follow-up examinations in childhood T-cell acute lymphoblastic leukemia and T-cell non-Hodgkin's lymphoma. Pediatr Blood Cancer; 2007 Apr;48(4):468-72
Genetic Alliance. consumer health - Lymphoblastic lymphoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The clinical value of follow-up examinations in childhood T-cell acute lymphoblastic leukemia and T-cell non-Hodgkin's lymphoma.
  • BACKGROUND: The aim of this study was to evaluate the value of follow-up investigations of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell non-Hodgkin's lymphoma (T-NHL), including cerebrospinal fluid (CSF) examination, bone marrow (BM) aspiration, peripheral blood (PB) count, serum lactate dehydrogenase (LDH) and chest X-rays in patients with an initial mediastinal enlargement.
  • PROCEDURE: We reviewed clinical records of all T-ALL patients from 1987 to 2002 and all T-NHL patients from 1977 to 2002, seen at a single institution.
  • All T-ALL and T-NHL patients with a mediastinal relapse were symptomatic.
  • [MeSH-major] Leukemia-Lymphoma, Adult T-Cell / diagnosis. Lymphoma, T-Cell / diagnosis


64. Camoni L, Federico B, Capelli G, Salfa MC, Regine V, Nicoletti G, Canuzzi P, Magliocchetti N, Suligoi B, Gruppo di Studio sui SERT: [Proportion of drug users in treatment who have never undergone serological testing for HIV, HBV and HCV and correlates of failure to undergo testing: Italy, 2005-2007]. Ann Ig; 2009 Jul-Aug;21(4):315-27
MedlinePlus Health Information. consumer health - Opioid Abuse and Addiction.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Proporzione di tossicodipendenti in trattamento che non hanno mai eseguito i test sierologici per HIV, HBV e HCV e fattori correlati alla mancata esecuzione: Italia, 2005-2007.
  • The failure to undergo testing among injectors was associated with a shorter history of drug use and with drug centres in central or southern Italy; these associations were also found among non-injectors, with the addition of low level of education.
  • [MeSH-minor] Adult. Cross-Sectional Studies. Female. Humans. Italy. Male. Middle Aged. Serologic Tests / utilization. Young Adult

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - Drug Abuse.
  • MedlinePlus Health Information. consumer health - Hepatitis B.
  • MedlinePlus Health Information. consumer health - Hepatitis C.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19798908.001).
  • [ISSN] 1120-9135
  • [Journal-full-title] Annali di igiene : medicina preventiva e di comunità
  • [ISO-abbreviation] Ann Ig
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  • [Investigator] Aliberti C; Epidio PS; Ardissone G; Bussana S; Astegiano G; Audino G; Gomma BE; Baccari M; Balestra R; Masala F; Barbato A; Beccerica E; Belsanti S; Burroni P; Capogrosso I; Cioffari P; Civitelli P; Coccia C; Consoli M; San Dalmazzo B; Conterno I; Panza C; Cuccuini M; Curcio F; Cutrì R; D'Ambra MF; D'Egidio P; Dadone P; Durano DL; Del Vecchio F; D'ell Aera S; Di Carlo M; Donadoni P; Farina P; Favignano L; Franco M; Gioè P; Grenci G; Leonetti A; Lopez A; Lupi AM; Casella P; Macrì F; Mantovani G; Orazi L; Pierantozzi M; Pennini G; sull'Adda T; Pieri MC; Pini D; Pioli E; Pirastu R; Poli C; Pontrelli MP; Possidente F; Profeta V; Pulvirenti L; Quagli S; Quaresima S; Raimondi G; Inferiore N; Richini M; Santini V; Scichilone L; Cataldo S; Soia M; Sparaco A; Tomassetti S
  •  go-up   go-down


65. Hundsdoerfer P, Dietrich I, Schmelz K, Eckert C, Henze G: XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL. Pediatr Blood Cancer; 2010 Aug;55(2):260-6
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Resistance to glucocorticoid induced apoptosis is one of the major risk factors for relapse and poor outcome in childhood acute lymphoblastic leukemia (ALL).
  • [MeSH-major] Gene Expression Regulation, Leukemic. Glucocorticoids / pharmacology. Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy. X-Linked Inhibitor of Apoptosis Protein / genetics
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / pharmacology. Bone Marrow Cells / pathology. Bone Marrow Examination. Child. Drug Resistance. Female. Humans. Leukemia-Lymphoma, Adult T-Cell / drug therapy. Male. Monocytes / pathology. Pharmacogenetics. Prognosis. RNA, Messenger / analysis. Treatment Outcome. Up-Regulation

  • MedlinePlus Health Information. consumer health - Steroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Wiley-Liss, Inc.
  • (PMID = 20582956.001).
  • [ISSN] 1545-5017
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Glucocorticoids; 0 / RNA, Messenger; 0 / X-Linked Inhibitor of Apoptosis Protein
  •  go-up   go-down


66. Marçais A, Jeannet R, Hernandez L, Soulier J, Sigaux F, Chan S, Kastner P: Genetic inactivation of Ikaros is a rare event in human T-ALL. Leuk Res; 2010 Apr;34(4):426-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Ikaros (Ikzf1) gene, encoding a transcription regulator, is a major tumor suppressor in B-cell acute lymphoblastic leukemia (B-ALL).
  • [MeSH-major] Gene Silencing. Ikaros Transcription Factor / genetics. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Cohort Studies. Comparative Genomic Hybridization. Gene Deletion. Gene Expression Regulation, Leukemic. Humans. Infant. Jurkat Cells. Middle Aged. Mutation / physiology. Protein Isoforms / genetics. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 Elsevier Ltd. All rights reserved.
  • [CommentIn] Leuk Res. 2010 Apr;34(4):416-7 [19892402.001]
  • (PMID = 19796813.001).
  • [ISSN] 1873-5835
  • [Journal-full-title] Leukemia research
  • [ISO-abbreviation] Leuk. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / IKZF1 protein, human; 0 / Protein Isoforms; 148971-36-2 / Ikaros Transcription Factor
  •  go-up   go-down


67. Pienkowska-Grela B, Witkowska A, Grygalewicz B, Rymkiewicz G, Rygier J, Woroniecka R, Walewski J: Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma. Cancer Genet Cytogenet; 2005 Jan 15;156(2):114-21
Genetics Home Reference. consumer health - chromosome 8.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma.
  • Translocations involving chromosome 8 are the most common aberrations in B-cell non-Hodgkin lymphoma (B-NHL).
  • [MeSH-minor] Adolescent. Adult. Aged. Chromosome Banding. Chromosome Mapping. Chromosomes, Human, Pair 14. Female. Flow Cytometry. Humans. In Situ Hybridization, Fluorescence. Karyotyping. Male. Middle Aged. Translocation, Genetic. Tumor Cells, Cultured

  • Genetic Alliance. consumer health - Hodgkin lymphoma.
  • Genetic Alliance. consumer health - Non-Hodgkin Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15642390.001).
  • [ISSN] 0165-4608
  • [Journal-full-title] Cancer genetics and cytogenetics
  • [ISO-abbreviation] Cancer Genet. Cytogenet.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Stanley B, Brodsky B, Nelson JD, Dulit R: Brief dialectical behavior therapy (DBT-B) for suicidal behavior and non-suicidal self injury. Arch Suicide Res; 2007;11(4):337-41
MedlinePlus Health Information. consumer health - Suicide.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Brief dialectical behavior therapy (DBT-B) for suicidal behavior and non-suicidal self injury.
  • The purpose of this study is to evaluate the effectiveness of a shorter course of Dialectical Behavior Therapy (DBT) in enhancing treatment retention and reducing: urges to engage in non-suicidal self injury (NSSI), NSSI, suicide ideation, and subjective distress in borderline personality disorder (BPD).
  • [MeSH-minor] Adolescent. Adult. Female. Humans. Male. Middle Aged. Pilot Projects

  • MedlinePlus Health Information. consumer health - Self-harm.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17882621.001).
  • [ISSN] 1381-1118
  • [Journal-full-title] Archives of suicide research : official journal of the International Academy for Suicide Research
  • [ISO-abbreviation] Arch Suicide Res
  • [Language] eng
  • [Grant] United States / NIMH NIH HHS / MH / MH061017; United States / NIMH NIH HHS / MH / MH062665; United States / NIAAA NIH HHS / AA / P20 AA015630
  • [Publication-type] Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Netherlands
  •  go-up   go-down


69. Nakayama Y, Kudo K, Ohtsuki T: Variability and fluctuation in running gait cycle of trained runners and non-runners. Gait Posture; 2010 Mar;31(3):331-5
MedlinePlus Health Information. consumer health - Exercise and Physical Fitness.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Variability and fluctuation in running gait cycle of trained runners and non-runners.
  • The current study examined variability and fluctuation in the running gait cycle, focusing on differences between trained distance runners and non-runners.
  • The average preferred speed was significantly higher for the trained runners than for the non-runners.
  • The trained runners showed significantly smaller variability of stride interval than did the non-runners, and at the same time the scaling exponent alpha evaluated by detrended fluctuation analysis tended to be smaller for the trained runners.
  • [MeSH-minor] Biomechanical Phenomena. Humans. Least-Squares Analysis. Male. Physical Education and Training. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Elsevier B.V. All rights reserved.
  • (PMID = 20056419.001).
  • [ISSN] 1879-2219
  • [Journal-full-title] Gait & posture
  • [ISO-abbreviation] Gait Posture
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


70. Chhuy T, Mansour G, Zejli A, Bouquigny C, Bock S, Abboud P: [Group B streptococcus screening: a retrospective study in 1,674 pregnancies]. J Gynecol Obstet Biol Reprod (Paris); 2005 Jun;34(4):328-33

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSION: We were surprised by our low rate of GBS carriage and the non optimal application of antibiotics during labor.
  • [MeSH-minor] Adult. Anti-Bacterial Agents / administration & dosage. Delivery, Obstetric. Female. Humans. Infant, Newborn. Pregnancy. Retrospective Studies. Streptococcal Infections / prevention & control. Vagina / microbiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16136658.001).
  • [ISSN] 0368-2315
  • [Journal-full-title] Journal de gynécologie, obstétrique et biologie de la reproduction
  • [ISO-abbreviation] J Gynecol Obstet Biol Reprod (Paris)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  •  go-up   go-down


71. Kozou H, Kujala T, Shtyrov Y, Toppila E, Starck J, Alku P, Näätänen R: The effect of different noise types on the speech and non-speech elicited mismatch negativity. Hear Res; 2005 Jan;199(1-2):31-9
MedlinePlus Health Information. consumer health - Noise.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effect of different noise types on the speech and non-speech elicited mismatch negativity.
  • The effect of different types of real-life noise on the central auditory processing of speech and non-speech sounds was evaluated by the means of mismatch negativity and behavioral responses.
  • Subjects (19-34 years old; 6 males, 4 females) were presented, in separate conditions, with either speech or non-speech stimuli of approximately equal complexity in five background conditions: babble noise, industrial noise, traffic noise, wide band noise, and silent condition.
  • Whereas there were no effects of stimuli or noise on the behavioral responses, the MMN results revealed that speech and non-speech sounds are processed differently both in silent and noisy conditions.
  • Speech processing was more affected than non-speech processing in all noise conditions.
  • Moreover, different noise types had a differential effect on the pre-attentive discrimination, as reflected in MMN, on speech and non-speech sounds.
  • [MeSH-minor] Adult. Audiometry, Evoked Response. Audiometry, Pure-Tone. Auditory Threshold. Female. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15574298.001).
  • [ISSN] 0378-5955
  • [Journal-full-title] Hearing research
  • [ISO-abbreviation] Hear. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


72. Comitato R, Esposito T, Cerbo G, Angelini F, Varriale B, Cardone A: Impairment of spermatogenesis and enhancement of testicular germ cell apoptosis induced by exogenous all-trans-retinoic acid in adult lizard Podarcis sicula. J Exp Zool A Comp Exp Biol; 2006 Mar 1;305(3):288-98
Hazardous Substances Data Bank. TESTOSTERONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Impairment of spermatogenesis and enhancement of testicular germ cell apoptosis induced by exogenous all-trans-retinoic acid in adult lizard Podarcis sicula.
  • In this study, the effects of exogenous all-trans-retinoic acid (atRA) on spermatogenesis of a non-mammalian seasonal reproducer were investigated.
  • Daily intraperitoneal injections of atRA or atRA plus testosterone (atRA+T) were given for 2 weeks to adult males of the lizard Podarcis sicula.

  • Hazardous Substances Data Bank. ALL-TRANS-RETINOIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 Wiley-Liss, Inc.
  • (PMID = 16432891.001).
  • [ISSN] 1548-8969
  • [Journal-full-title] Journal of experimental zoology. Part A, Comparative experimental biology
  • [ISO-abbreviation] J. Exp. Zoolog. Part A Comp. Exp. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Retinoic Acid; 3XMK78S47O / Testosterone; 5688UTC01R / Tretinoin; 63231-63-0 / RNA
  •  go-up   go-down


73. Dik WA, Nadel B, Przybylski GK, Asnafi V, Grabarczyk P, Navarro JM, Verhaaf B, Schmidt CA, Macintyre EA, van Dongen JJ, Langerak AW: Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL. Blood; 2007 Jul 1;110(1):388-92

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We performed combined in vivo, ex vivo, and in silico analyses on 9 new t(11;14)(p13;q11)-positive T-cell acute lymphoblastic leukemia (T-ALL) as well as normal thymocytes.
  • [MeSH-major] Chromosome Breakage. DNA-Binding Proteins / genetics. Leukemia-Lymphoma, Adult T-Cell / genetics. Metalloproteins / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17360939.001).
  • [ISSN] 0006-4971
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / DNA-Binding Proteins; 0 / LIM Domain Proteins; 0 / LMO2 protein, human; 0 / Metalloproteins; 0 / Proto-Oncogene Proteins
  •  go-up   go-down


74. Sandler ES, Homans A, Mandell L, Amylon M, Wall DA, Devidas M, Buchanan GR, Lipton JM, Billett AL: Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia: a pediatric oncology group pilot feasibility study. J Pediatr Hematol Oncol; 2006 Apr;28(4):210-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia: a pediatric oncology group pilot feasibility study.
  • BACKGROUND: Relapsed acute lymphoblastic leukemia (ALL) in children is associated with a poor outcome, especially for those patients whose relapse occurs during the first 36 months after diagnosis.
  • PROCEDURE: Eligible patients with a bone marrow relapse of non-T, non-B ALL underwent a common induction and consolidation followed by receipt of either an allogeneic HSCT from a human leukocyte antigen (HLA)-identical sibling or an autologous HSCT purged with B-4 blocked ricin.
  • [MeSH-major] Bone Marrow / pathology. Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy. Stem Cell Transplantation
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols. Child. Child, Preschool. Female. Humans. Male. Pilot Projects. Recurrence. Treatment Outcome


75. Yoshino K, Osada H, Matsukubo T, Takaesu Y: Percentile curves for present teeth in smokers and non-smokers in an adult male population. Bull Tokyo Dent Coll; 2006 May;47(2):51-5
MedlinePlus Health Information. consumer health - Smoking.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Percentile curves for present teeth in smokers and non-smokers in an adult male population.
  • The purpose of this study was to obtain percentile curves for present teeth in smokers and non-smokers for use in oral health education.
  • They were classified into two groups: smokers and non-smokers.
  • Smokers had fewer teeth than non-smokers in all age groups (p<0.05).
  • At the age of 50, the 50th percentile for present teeth was 26 for smokers and 27 for non-smokers.
  • However, the 3rd percentile for smokers' present teeth was 20.5 at 40 years of age and 14 at 50 years of age, while for non-smokers it was 22.5 at 40 years of age and 19 at 50 years of age.
  • These data should be made available for use in adult oral health education.
  • [MeSH-minor] Adult. Humans. Male. Middle Aged. Statistics, Nonparametric. Surveys and Questionnaires

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17167220.001).
  • [ISSN] 0040-8891
  • [Journal-full-title] The Bulletin of Tokyo Dental College
  • [ISO-abbreviation] Bull. Tokyo Dent. Coll.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


76. Suwanrath-Kengpol C, Kor-anantakul O, Suntharasaj T, Leetanaporn R: Etiology and outcome of non-immune hydrops fetalis in southern Thailand. Gynecol Obstet Invest; 2005;59(3):134-7
Genetic Alliance. consumer health - Hydrops fetalis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Etiology and outcome of non-immune hydrops fetalis in southern Thailand.
  • OBJECTIVE: To study the etiology and outcome of non-immune hydrops fetalis in southern Thailand.
  • METHODS: The medical records and videotape recordings of all pregnant women diagnosed with non-immune fetal hydrops, from January 1993 to December 2002 were reviewed.
  • RESULTS: Non-immune hydrops fetalis was documented in 71 cases.
  • Homozygous alpha-thalassemia-1 dominated as the cause of non-immune fetal hydrops (28.2%), followed by structural abnormalities (15.5%) and infection (12.7%).
  • The overall survival rate of non-immune hydrops fetalis cases was 4.2%.
  • CONCLUSIONS: Homozygous alpha-thalassemia-1 is the most common cause of non-immune hydrops fetalis in southern Thailand, and the overall prognosis of non-immune hydrops fetalis is poor.
  • [MeSH-minor] Adolescent. Adult. Aneuploidy. Female. Gestational Age. Heart Defects, Congenital / complications. Hemoglobins, Abnormal. Humans. Infection / complications. Maternal Age. Middle Aged. Pregnancy. Thailand

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2005 S. Karger AG, Basel.
  • (PMID = 15637431.001).
  • [ISSN] 0378-7346
  • [Journal-full-title] Gynecologic and obstetric investigation
  • [ISO-abbreviation] Gynecol. Obstet. Invest.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Hemoglobins, Abnormal; 9056-09-1 / hemoglobin Bart's
  •  go-up   go-down


77. Smith BN, Bean MK, Mitchell KS, Speizer IS, Fries EA: Psychosocial factors associated with non-smoking adolescents' intentions to smoke. Health Educ Res; 2007 Apr;22(2):238-47
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Psychosocial factors associated with non-smoking adolescents' intentions to smoke.
  • Most adult smokers began smoking during adolescence, making youth tobacco prevention an especially important public health goal.
  • Attitudes, subjective norms (and other normative factors) and perceived behavioral control were all associated with non-smokers' intentions to smoke.
  • Findings are consistent with the TPB--attitudes, normative factors and perceived behavioral control each helped account for non-smoking adolescents' intentions to smoke.

  • MedlinePlus Health Information. consumer health - Child Behavior Disorders.
  • MedlinePlus Health Information. consumer health - Smoking.
  • MedlinePlus Health Information. consumer health - Smoking and Youth.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16880217.001).
  • [ISSN] 0268-1153
  • [Journal-full-title] Health education research
  • [ISO-abbreviation] Health Educ Res
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


78. Becque T, White IR: Regaining power lost by non-compliance via full probability modelling. Stat Med; 2008 Nov 29;27(27):5640-63
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Regaining power lost by non-compliance via full probability modelling.
  • Non-compliance, or non-receipt of randomized intervention, is a common problem in randomized controlled trials.
  • We explore the possibility of regaining some of this power in a setting with all-or-nothing compliance, without making any assumptions about the comparability of compliers and non-compliers.
  • [MeSH-minor] Adult. Female. Follow-Up Studies. Humans. Male. Surveys and Questionnaires. Time Factors. Treatment Outcome. Unemployment

  • MedlinePlus Health Information. consumer health - Depression.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2008 John Wiley & Sons, Ltd.
  • (PMID = 18712776.001).
  • [ISSN] 0277-6715
  • [Journal-full-title] Statistics in medicine
  • [ISO-abbreviation] Stat Med
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / MC/ U105260558; United Kingdom / Medical Research Council / /
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


79. Whitty AG, Murphy AJ, Coutts AJ, Watsford ML: Factors associated with the selection of the freely chosen cadence in non-cyclists. Eur J Appl Physiol; 2009 Jul;106(5):705-12
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Factors associated with the selection of the freely chosen cadence in non-cyclists.
  • The purpose of this study was to examine both the freely chosen cadence (FCC) and the physical variables associated with cadence selection in non-cyclists.
  • The findings suggested that the FCC in non-cyclists was more closely related to variables that minimise muscle strain and mechanical load than those associated with minimising metabolic economy.
  • [MeSH-minor] Adult. Biomechanical Phenomena. Efficiency / physiology. Humans. Male. Perception / physiology. Physical Exertion / physiology. Torque. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Sports Med. 2000 Jan;21(1):60-4 [10683101.001]
  • [Cites] J Mot Behav. 1987 Jun;19(2):240-64 [14988061.001]
  • [Cites] Med Sci Sports Exerc. 2000 Sep;32(9):1630-4 [10994916.001]
  • [Cites] Eur J Appl Physiol Occup Physiol. 1999 Nov-Dec;80(6):555-63 [10541922.001]
  • [Cites] Int J Sports Med. 1982 Aug;3(3):153-8 [7129724.001]
  • [Cites] Med Sci Sports Exerc. 1995 Feb;27(2):217-25 [7723645.001]
  • [Cites] Med Sci Sports. 1974 Winter;6(4):226-31 [4461982.001]
  • [Cites] Med Sci Sports. 1977 Summer;9(2):113-7 [895427.001]
  • [Cites] Med Sci Sports Exerc. 1990 Aug;22(4):512-6 [2402213.001]
  • [Cites] J Biomech. 1988;21(10):839-49 [3225270.001]
  • [Cites] Med Sci Sports Exerc. 1998 Jun;30(6):942-8 [9624655.001]
  • [Cites] Med Sci Sports Exerc. 2000 Jul;32(7):1281-7 [10912894.001]
  • [Cites] J Biomech. 2005 May;38(5):1003-10 [15797582.001]
  • [Cites] Acta Physiol Scand. 2002 Nov;176(3):185-94 [12392498.001]
  • [Cites] Med Sci Sports Exerc. 1997 Sep;29(9):1225-32 [9309635.001]
  • [Cites] J Biomech. 1986;19(4):317-29 [3711132.001]
  • [Cites] J Appl Biomech. 1998 Aug;14 (3):276-291 [28121252.001]
  • [Cites] Eur J Appl Physiol. 2001 Aug;85(3-4):392-5 [11560096.001]
  • [Cites] Med Sci Sports Exerc. 1980;12(5):345-51 [7453512.001]
  • [Cites] Med Sci Sports Exerc. 1993 Nov;25(11):1269-74 [8289615.001]
  • [Cites] Eur J Appl Physiol. 2004 Jun;92(1-2):114-20 [15024664.001]
  • [Cites] J Appl Physiol Respir Environ Exerc Physiol. 1981 Aug;51(2):447-51 [7263451.001]
  • [Cites] J Biomech. 2002 Feb;35(2):277-85 [11784546.001]
  • [Cites] Med Sci Sports Exerc. 2002 Oct;34(10):1645-52 [12370567.001]
  • [Cites] Med Sci Sports Exerc. 1996 Dec;28(12):1492-7 [8970143.001]
  • [Cites] Med Sci Sports Exerc. 1992 Apr;24(4):467-74 [1560745.001]
  • (PMID = 19430807.001).
  • [ISSN] 1439-6327
  • [Journal-full-title] European journal of applied physiology
  • [ISO-abbreviation] Eur. J. Appl. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] Germany
  •  go-up   go-down


80. Vas T, Wagner Z, Jenei V, Varga Z, Kovács T, Wittmann I, Schinzel R, Balla G, Balla J, Heidland A, Nagy J: Oxidative stress and non-enzymatic glycation in IgA nephropathy. Clin Nephrol; 2005 Nov;64(5):343-51
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oxidative stress and non-enzymatic glycation in IgA nephropathy.
  • In this study we assess oxidative stress, non-enzymatic glycation, oxidative resistance of low-density lipoprotein and its alpha-tocopherol content in these patients.
  • PATIENTS AND METHODS: Non-enzymatic glycation and oxidative stress were assessed in 88 IgA nephropathy patients by measuring advanced glycation end products, Nepsilon-carboxymethyl-lysine, thiobarbituric acid reactive substances, oxidative resistance of low-density lipoprotein and its alpha-tocopherol content.
  • CONCLUSIONS: Decreased oxidative resistance of low-density lipoprotein and enhanced oxidative stress are common features in IgA nephropathy, while increased non-enzymatic glycation occurs as renal function declines.
  • [MeSH-minor] Adult. Female. Glycosylation. Glycosylation End Products, Advanced / metabolism. Humans. Lipoproteins, LDL / metabolism. Male. Middle Aged. alpha-Tocopherol / metabolism

  • Hazardous Substances Data Bank. VITAMIN E .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16312261.001).
  • [ISSN] 0301-0430
  • [Journal-full-title] Clinical nephrology
  • [ISO-abbreviation] Clin. Nephrol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Glycosylation End Products, Advanced; 0 / Lipoproteins, LDL; H4N855PNZ1 / alpha-Tocopherol
  •  go-up   go-down


81. Wierzbicka M, Kopeć T, Szyfter W, Bem G: [Epidemiology of non-malignant salivary gland tumours based on 675 cases]. Otolaryngol Pol; 2010 Sep-Oct;64(5):281-7
MedlinePlus Health Information. consumer health - Salivary Gland Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Epidemiology of non-malignant salivary gland tumours based on 675 cases].
  • This work aims at the assessment of the frequency of occurrence of non-malignant neoplasm in parotid and submandibular gland based on the material collected at the ENT Department of the Medical University in Poznan in the years 1995-2006.
  • The number of non-malignant neoplasm was 675, and the number of malignant neoplasm was 103.
  • With regard to paroid glands, 586 non-malignant tumours and 82 malignant tumours were identified, with regard to submandibular glands the numbers were respectively: 89 and 21.
  • Main aim of this work has been achieved through the execution of partial steps: the analysis of the trends in occurrence of non-malignant neoplasm in the 12-year period, the analysis of the epidemiological differences: sex, age, place of residence - town or country, duration of symptoms, diameter of the tumour at the time the patient reported for treatment, histological structures that were carried on the basis of the comparison of data collected in the two periods of time: period I--the years 1995-2000 and period II--the years 2001-2006.
  • The frequency of operations on non-malignant tumours of salivary glands (as compared to the total number of operations) was 4.11% in the first period and 4.18% in the second.
  • The diameter of the non-malignant tumours undergoing operation ranged from 1 cm to 8 cm, with the average being 3 cm.
  • [MeSH-minor] Adult. Age Distribution. Age Factors. Aged. Female. Humans. Incidence. Male. Middle Aged. Neoplasm Staging. Poland / epidemiology. Prognosis. Salivary Gland Neoplasms / epidemiology. Salivary Gland Neoplasms / pathology. Salivary Glands / pathology. Young Adult

  • MedlinePlus Health Information. consumer health - Rural Health Concerns.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21166137.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


82. Akoum R, Brihi E, Saade M, Hanna T, Chahine G: Salvage abdominal irradiation for refractory non-Hodgkin's lymphoma. J Cancer Res Ther; 2007 Jul-Sep;3(3):143-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Salvage abdominal irradiation for refractory non-Hodgkin's lymphoma.
  • BACKGROUND: Abdominal irradiation, as a part of treatment, is often ignored in the management of refractory non-Hodgkin's lymphoma (NHL).
  • [MeSH-major] Lymphoma, Non-Hodgkin / radiotherapy. Salvage Therapy
  • [MeSH-minor] Abdomen. Adult. Aged. Female. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18079576.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


83. Kuzawa CW, Gettler LT, Huang YY, McDade TW: Mothers have lower testosterone than non-mothers: evidence from the Philippines. Horm Behav; 2010 Apr;57(4-5):441-7
Hazardous Substances Data Bank. TESTOSTERONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mothers have lower testosterone than non-mothers: evidence from the Philippines.
  • Compared to non-mothers and non-pairbonded women, mothers and pairbonded women had 32% (p<0.0001) and 23% (p<0.004) lower waking T, respectively, but similar evening T.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • [Cites] Proc Biol Sci. 2009 Jan 22;276(1655):347-54 [18826936.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Aug;85(8):2839-53 [10946892.001]
  • [Cites] Acta Obstet Gynecol Scand. 2001 Apr;80(4):326-30 [11264607.001]
  • [Cites] Mayo Clin Proc. 2001 Jun;76(6):582-92 [11393496.001]
  • [Cites] Biol Psychol. 2001 Sep;58(1):41-7 [11473794.001]
  • [Cites] Circulation. 2001 Aug 28;104(9):1034-9 [11524398.001]
  • [Cites] Horm Behav. 2001 Sep;40(2):139-45 [11534974.001]
  • [Cites] J Sex Marital Ther. 2001 Oct-Dec;27(5):513-9 [11554213.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2001 Dec;281(6):E1172-81 [11701431.001]
  • [Cites] Horm Behav. 2002 Aug;42(1):62-9 [12191648.001]
  • [Cites] Psychoneuroendocrinology. 2003 Apr;28(3):364-75 [12573302.001]
  • [Cites] Am J Clin Nutr. 2003 Apr;77(4):960-6 [12663298.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E197-205 [12670837.001]
  • [Cites] Am J Phys Anthropol. 2003 Nov;122(3):279-86 [14533186.001]
  • [Cites] Psychoneuroendocrinology. 2004 Oct;29(9):1153-62 [15219639.001]
  • [Cites] Psychoneuroendocrinology. 2005 Jan;30(1):58-71 [15358443.001]
  • [Cites] J Clin Endocrinol Metab. 1974 Aug;39(2):340-6 [4278727.001]
  • [Cites] J Reprod Fertil. 1980 Mar;58(2):537-49 [6776267.001]
  • [Cites] Clin Chim Acta. 1982 Aug 18;123(3):287-92 [6811163.001]
  • [Cites] Br J Psychiatry. 1986 Jan;148:74-9 [3955323.001]
  • [Cites] Physiol Behav. 1990 Jul;48(1):83-6 [2236282.001]
  • [Cites] J Clin Endocrinol Metab. 1992 Dec;75(6):1503-7 [1464655.001]
  • [Cites] Demography. 1993 Feb;30(1):63-80 [8440399.001]
  • [Cites] Horm Behav. 1997 Apr;31(2):145-58 [9154435.001]
  • [Cites] Horm Behav. 1997 Oct;32(2):85-98 [9367716.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Apr;83(4):1312-8 [9543161.001]
  • [Cites] Horm Behav. 2005 Jan;47(1):39-48 [15579264.001]
  • [Cites] Obstet Gynecol. 2005 May;105(5 Pt 1):944-52 [15863529.001]
  • [Cites] JAMA. 2005 Jul 6;294(1):91-6 [15998895.001]
  • [Cites] Arch Intern Med. 2005 Jul 25;165(14):1582-9 [16043675.001]
  • [Cites] Am Nat. 2005 Oct;166 Suppl 4:S85-98 [16224714.001]
  • [Cites] Physiol Behav. 2006 Jan 30;87(1):135-43 [16233905.001]
  • [Cites] Proc Biol Sci. 2006 Feb 7;273(1584):333-9 [16543176.001]
  • [Cites] Psychoneuroendocrinology. 2006 Jul;31(6):715-23 [16621328.001]
  • [Cites] Am Nat. 2007 Jan;169(1):142-9 [17206593.001]
  • [Cites] Horm Behav. 2007 Feb;51(2):286-91 [17196592.001]
  • [Cites] Horm Behav. 2007 Mar;51(3):454-9 [17316638.001]
  • [Cites] Horm Behav. 2007 Apr;51(4):463-76 [17320880.001]
  • [Cites] Horm Behav. 2007 Apr;51(4):477-82 [17320881.001]
  • [Cites] Contraception. 2007 Jul;76(1):8-17 [17586130.001]
  • [Cites] Psychol Sci. 2007 Nov;18(11):965-70 [17958710.001]
  • [Cites] N Engl J Med. 2008 Nov 6;359(19):2005-17 [18987368.001]
  • [Cites] Psychoneuroendocrinology. 2009 Aug;34(7):1056-64 [19278791.001]
  • [Cites] Am J Hum Biol. 2009 Jul-Aug;21(4):559-66 [19298003.001]
  • [Cites] Horm Behav. 2009 Oct;56(4):429-35 [19651129.001]
  • (PMID = 20122934.001).
  • [ISSN] 1095-6867
  • [Journal-full-title] Hormones and behavior
  • [ISO-abbreviation] Horm Behav
  • [Language] ENG
  • [Grant] United States / NIEHS NIH HHS / ES / P30 ES010126; United States / NIMH NIH HHS / MH / T32 MH075854; United States / NIEHS NIH HHS / ES / ES10126; United States / NCRR NIH HHS / RR / P20 RR020649; United States / NCRR NIH HHS / RR / RR20649; United States / NIMH NIH HHS / MH / T32 MH075854-03; United States / NIMH NIH HHS / MH / MH075854-03
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contraceptive Agents, Female; 3XMK78S47O / Testosterone
  • [Other-IDs] NLM/ NIHMS182119; NLM/ PMC2857926
  •  go-up   go-down


84. Abdel-Khalek AM: Death anxiety in clinical and non-clinical groups. Death Stud; 2005 Apr;29(3):251-9
MedlinePlus Health Information. consumer health - Opioid Abuse and Addiction.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Death anxiety in clinical and non-clinical groups.
  • The Arabic Scale of Death Anxiety (ASDA) was administered, individually, to 7 groups (N = 765) of Egyptian normal participants (non-clinical), anxiety disorder patients, and patients suffering from schizophrenia (males and females), and addicts (males only).
  • The female and male anxiety disorder patients means were, respectively, significantly higher than the means of the other 5 groups on the ASDA, while male schizophrenics attained the lowest mean score in proportion to all the other 6 groups, including the non-clinical 2 groups.
  • [MeSH-minor] Adult. Arabs / psychology. Egypt. Female. Humans. Male. Psychometrics. Sex Factors


85. Wang H, Lei W, Li Y, Xu T: The epidemiology of non-traumatic prehospital sudden death in Macau. Resuscitation; 2007 Aug;74(2):222-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The epidemiology of non-traumatic prehospital sudden death in Macau.
  • OBJECTIVE: To understand the epidemiology of non-traumatic prehospital sudden death (NPSD) in Macau, and to discuss potential diseases related to NPSD.
  • [MeSH-minor] Adult. Age Factors. Aged. Cause of Death. Female. Humans. Incidence. Macau / epidemiology. Male. Middle Aged. Resuscitation. Risk Factors. Sex Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17382450.001).
  • [ISSN] 0300-9572
  • [Journal-full-title] Resuscitation
  • [ISO-abbreviation] Resuscitation
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


86. Sambol SZ, Stimac D, Orlić ZC, Guina T: Haematological, biochemical and bone density parameters in vegetarians and non-vegetarians. West Indian Med J; 2009 Dec;58(6):512-7
Hazardous Substances Data Bank. IRON, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Haematological, biochemical and bone density parameters in vegetarians and non-vegetarians.
  • OBJECTIVE: The objective is to determine any possible differences between haematological, biochemical and bone mineral density in vegetarians (vegans and lacto-ovovegetarians) and non-vegeterians.
  • METHODS: The examined group consisted of 100 individuals: 50 non-vegetarians and 50 vegetarians.
  • RESULTS: The results showed that lacto-ovovegetarians had statistically significantly higher red blood cell counts and haematocrit values than non-vegetarians.
  • Vegans also had higher haematocrit values than non-vegetarians.
  • Iron levels were lower in non-vegetarians than in vegans and lacto-ovovegetarians.
  • Non-vegetarians had much higher levels of cholesterol, triglycerides and LDL than the other two groups, but there were no differences found between same values in vegans and lacto-ovovegetarians.
  • [MeSH-minor] Adult. Blood Glucose / metabolism. Case-Control Studies. Erythrocyte Count. Female. Hematocrit. Hemoglobinometry. Humans. Iron / blood. Male. Middle Aged. Young Adult

  • MedlinePlus Health Information. consumer health - Bone Density.
  • MedlinePlus Health Information. consumer health - Vegetarian Diet.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20583676.001).
  • [ISSN] 0043-3144
  • [Journal-full-title] The West Indian medical journal
  • [ISO-abbreviation] West Indian Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Jamaica
  • [Chemical-registry-number] 0 / Blood Glucose; 0 / Lipids; E1UOL152H7 / Iron
  •  go-up   go-down


87. Bouchard SS, Murphy AK, Berry JA: Non-additive dietary effects in juvenile slider turtles, Trachemys scripta. Comp Biochem Physiol A Mol Integr Physiol; 2010 Feb;155(2):264-70
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-additive dietary effects in juvenile slider turtles, Trachemys scripta.
  • Non-additive dietary effects occur when nutritional gains from a mixed diet are greater than or less than that predicted by summing the gains from individual diet items.
  • Both positive and negative effects occur in adult slider turtles, Trachemys scripta.
  • The purpose of this study was to determine if juveniles experience non-additive effects and to assess the underlying mechanism.
  • Similar to adults, a negative non-additive effect was demonstrated on the 19% shrimp and 22% cricket diets.
  • Intake varied dramatically between the plant and animal diets, resulting in differences in transit time that could explain the non-additive effect.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2009 Elsevier Inc. All rights reserved.
  • (PMID = 19931632.001).
  • [ISSN] 1531-4332
  • [Journal-full-title] Comparative biochemistry and physiology. Part A, Molecular & integrative physiology
  • [ISO-abbreviation] Comp. Biochem. Physiol., Part A Mol. Integr. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


88. Henty K, Wells RM, Brittain T: Characterization of the hemoglobins of the adult brushtailed possum, Trichosurus vulpecula (Kerr) reveals non-genetic heterogeneity. Comp Biochem Physiol A Mol Integr Physiol; 2007 Nov;148(3):498-503
Hazardous Substances Data Bank. OXYGEN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of the hemoglobins of the adult brushtailed possum, Trichosurus vulpecula (Kerr) reveals non-genetic heterogeneity.
  • The hemoglobins contained within the red blood cells of the adult brushtail possum exhibited cooperative (n=2.6) oxygen binding curves with an associated p50 of 38 mm Hg at pH 7.4 and a large Bohr effect (-0.60).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17689995.001).
  • [ISSN] 1095-6433
  • [Journal-full-title] Comparative biochemistry and physiology. Part A, Molecular & integrative physiology
  • [ISO-abbreviation] Comp. Biochem. Physiol., Part A Mol. Integr. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amides; 0 / Chlorides; 0 / Hemoglobins; 0 / Oxyhemoglobins; 0 / Protein Isoforms; 0 / Protein Subunits; 138-81-8 / 2,3-Diphosphoglycerate; 8L70Q75FXE / Adenosine Triphosphate; GAN16C9B8O / Glutathione; S88TT14065 / Oxygen
  •  go-up   go-down


89. Cecchinato V, Erba E, Basile A, Scarpati B, Fazi C, Brando B, Comi P, Chiaramonte R: Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines. Leuk Res; 2008 May;32(5):791-7
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • T acute lymphoblastic leukemia cell lines treated with hexamethylene bisacetamide (HMBA) undergo a delay in cell cycle progression and increase susceptibility to apoptosis, although they never overcome the differentiation block.
  • Even if HMBA generally reduces Notch1 level in T acute lymphoblastic leukemia (T-ALL) cell lines, this does not commonly influence the biological response; in fact all the analysed cell lines, except CEM cells, display no biological effect following DAPT-induced Notch inhibition.
  • [MeSH-major] Acetamides / pharmacology. Antineoplastic Agents / pharmacology. Leukemia-Lymphoma, Adult T-Cell / drug therapy

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Leuk Res. 2008 May;32(5):689-90 [18164760.001]
  • (PMID = 17964649.001).
  • [ISSN] 0145-2126
  • [Journal-full-title] Leukemia research
  • [ISO-abbreviation] Leuk. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Acetamides; 0 / Antineoplastic Agents; 0 / NOTCH1 protein, human; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Receptor, Notch1; 0 / Triglycerides; 0 / Tumor Suppressor Protein p53; 56-12-2 / gamma-Aminobutyric Acid; 93349-26-9 / 1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol; EC 2.7.11.22 / CDK4 protein, human; EC 2.7.11.22 / Cyclin-Dependent Kinase 4; LA133J59VU / hexamethylene bisacetamide
  •  go-up   go-down


90. Rose JE, Behm FM, Murugesan T, McClernon FJ: Silver acetate interactions with nicotine and non-nicotine smoke components. Exp Clin Psychopharmacol; 2010 Dec;18(6):462-9
Hazardous Substances Data Bank. NICOTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Silver acetate interactions with nicotine and non-nicotine smoke components.
  • This study explored the basic mechanistic question of whether topical oral silver acetate solution interacts with nicotine as opposed to non-nicotine smoke constituents.
  • These results support the conclusion that silver acetate not only renders the taste of cigarette smoke less appealing, but also that the compound appears to interact selectively with non-nicotine smoke constituents.
  • [MeSH-minor] Adult. Double-Blind Method. Female. Humans. Male. Middle Aged. Nicotinic Agonists / administration & dosage. Nicotinic Agonists / chemistry. Taste. Tobacco / chemistry

  • MedlinePlus Health Information. consumer health - Quitting Smoking.
  • MedlinePlus Health Information. consumer health - Smoking.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. SILVER COMPOUNDS .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] PsycINFO Database Record (c) 2010 APA, all rights reserved.
  • (PMID = 21186921.001).
  • [ISSN] 1936-2293
  • [Journal-full-title] Experimental and clinical psychopharmacology
  • [ISO-abbreviation] Exp Clin Psychopharmacol
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Acetates; 0 / Nicotinic Agonists; 0 / Silver Compounds; 19PPS85F9H / silver acetate; 6M3C89ZY6R / Nicotine
  •  go-up   go-down


91. Krenn V, Morawietz L, Burmester GR, Häupl T: [Synovialitis score: histopathological grading system for chronic rheumatic and non-rheumatic synovialitis]. Z Rheumatol; 2005 Jun;64(5):334-42
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Synovialitis score: histopathological grading system for chronic rheumatic and non-rheumatic synovialitis].
  • Standardization of the histopathological assessment of synovial membrane specimens might facilitate the diagnosis of chronic rheumatic and non-rheumatic joint diseases.
  • The proposed synovialitis score is based on well definable histopathologic criteria and contributes to the diagnosis of rheumatic and non-rheumatic joint diseases.
  • [MeSH-minor] Adolescent. Adult. Aged. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Observer Variation. Reproducibility of Results. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Rheumatoid Arthritis.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arthritis Rheum. 1998 Aug;41(8):1378-87 [9704635.001]
  • [Cites] Hum Pathol. 2001 Jan;32(1):81-8 [11172299.001]
  • [Cites] Arthritis Rheum. 1996 Jul;39(7):1077-81 [8670314.001]
  • [Cites] CA Cancer J Clin. 1979 Mar-Apr;29(2):66-77 [219944.001]
  • [Cites] Pathol Int. 1999 Apr;49(4):298-304 [10365848.001]
  • [Cites] Can J Gastroenterol. 2001 Sep;15(9):591-8 [11573102.001]
  • [Cites] Arthritis Rheum. 1989 Apr;32(4):361-9 [2468336.001]
  • [Cites] Arthritis Rheum. 1986 Aug;29(8):1039-49 [3741515.001]
  • [Cites] Cell Mol Biol (Noisy-le-grand). 2002;48 Online Pub:OL243-9 [12643440.001]
  • [Cites] Rheumatology (Oxford). 2000 Jan;39(1):43-9 [10662872.001]
  • [Cites] Semin Arthritis Rheum. 1973;3(1):55-78 [4581554.001]
  • [Cites] Arthritis Res Ther. 2004;6(4):140-6 [15225356.001]
  • [Cites] Pathol Res Pract. 2002;198(5):317-25 [12092767.001]
  • [Cites] Z Rheumatol. 1974 Mar-Apr;33(3):73-86 [4600422.001]
  • [Cites] Pathol Annu. 1980;15(Pt 1):239-51 [7443307.001]
  • [Cites] J Rheumatol. 2000 Sep;27(9):2185-92 [10990232.001]
  • [Cites] Rheumatology (Oxford). 1999 Nov;38(11):1074-80 [10556258.001]
  • [Cites] Kidney Int. 2004 Feb;65(2):521-30 [14717922.001]
  • [Cites] Arthritis Rheum. 1988 Mar;31(3):315-24 [3358796.001]
  • [Cites] Br J Rheumatol. 1998 Jun;37(6):636-42 [9667617.001]
  • [Cites] Arthritis Rheum. 1997 Feb;40(2):217-25 [9041933.001]
  • [Cites] Arthritis Rheum. 1998 Apr;41(4):663-9 [9550475.001]
  • [Cites] J Clin Pathol. 1968 Sep;21(5):656-60 [5697370.001]
  • [Cites] J Rheumatol. 1988 Jun;15(6):885-7 [3047382.001]
  • [Cites] Z Rheumatol. 2002 Aug;61(4):396-404 [12426845.001]
  • (PMID = 15965818.001).
  • [ISSN] 0340-1855
  • [Journal-full-title] Zeitschrift fur Rheumatologie
  • [ISO-abbreviation] Z Rheumatol
  • [Language] ger
  • [Publication-type] Clinical Trial; Controlled Clinical Trial; English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


92. Kerwin AJ, Frykberg ER, Schinco MA, Griffen MM, Murphy T, Tepas JJ: The effect of early spine fixation on non-neurologic outcome. J Trauma; 2005 Jan;58(1):15-21
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effect of early spine fixation on non-neurologic outcome.
  • We hypothesized that compliance with an early spinal fracture fixation protocol (within 3 days of admission) would improve non-neurologic outcome in patients with spinal fractures.
  • CONCLUSIONS: Reasonable compliance with an early spinal fracture fixation protocol produced some outcome improvements in non-neurologic outcome.
  • [MeSH-minor] Adult. Chi-Square Distribution. Female. Humans. Incidence. Injury Severity Score. Length of Stay / statistics & numerical data. Male. Middle Aged. Pneumonia / epidemiology. Pneumonia / etiology. Pneumonia / prevention & control. Registries. Time Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Spine Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15674144.001).
  • [ISSN] 0022-5282
  • [Journal-full-title] The Journal of trauma
  • [ISO-abbreviation] J Trauma
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


93. Corti M, Villafañe Fioti MF, Lewi D, Schtirbu R, Narbaitz M, de Dios Soler M: [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients]. Acta Gastroenterol Latinoam; 2006 Dec;36(4):190-6
HIV InSite. treatment guidelines - Clinical Implications of Immune Reconstitution in AIDS .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
  • BACKGROUND: Non-Hodgkin's lymphoma (NHL) is the second most common neoplasm among patients with AIDS.
  • The global incidence of AIDS-associated lymphomas (central nervous system lymphomas, non-Hodgkin lymphomas and Hodgkin lymphoma) during the time of study was 2,9% (54 cases); 17 patients (32%) had diagnosis of systemic NHL; 10 (58,8%) of them were extranodal at the onset of clinical symptoms and 8 (80%) involvement the digestive tract and anexal glands (parotid gland, cavum, esophagus, stomach, duodenum, the right colon in 2 patients and the liver), as primary NHL of high grade and "B" phenotype.
  • [MeSH-major] Gastrointestinal Neoplasms / diagnosis. Liver Neoplasms / diagnosis. Lymphoma, AIDS-Related / diagnosis. Lymphoma, Non-Hodgkin / diagnosis. Parotid Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Male. Neoplasm Staging. Prognosis. Retrospective Studies. Survival Analysis

  • Genetic Alliance. consumer health - AIDS-HIV.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17225446.001).
  • [ISSN] 0300-9033
  • [Journal-full-title] Acta gastroenterologica Latinoamericana
  • [ISO-abbreviation] Acta Gastroenterol. Latinoam.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Argentina
  •  go-up   go-down


94. Kotsopoulos I, de Krom M, Kessels F, Lodder J, Troost J, Twellaar M, van Merode T, Knottnerus A: Incidence of epilepsy and predictive factors of epileptic and non-epileptic seizures. Seizure; 2005 Apr;14(3):175-82
MedlinePlus Health Information. consumer health - Seizures.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence of epilepsy and predictive factors of epileptic and non-epileptic seizures.
  • PURPOSE: To estimate the incidence of unprovoked seizures (US) and epilepsy in a general population from the southern part of the Netherlands, in relation to age, sex, etiology and seizure type, and to identify predictive factors of the epileptic and non-epileptic seizures.
  • A predictive profile for the occurrence of epileptic and non-epileptic seizures was obtained by stepwise logistic regression analysis.
  • Predictors for epileptic versus non-epileptic seizures of organic origin were an epileptiform EEG pattern (OR=0.06) versus a history of hypertension (OR=2.8) or cardiovascular disease (OR=5.4).
  • Strong predictors for seizures of non-organic origin were female sex (OR=2.2) and head injury (OR=2.4).
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Cross-Sectional Studies. Diagnosis, Differential. Electroencephalography. Female. Humans. Incidence. Logistic Models. Male. Middle Aged. Netherlands / epidemiology. Odds Ratio. Predictive Value of Tests. Prospective Studies. Sex Distribution

  • Genetic Alliance. consumer health - Epilepsy.
  • Genetic Alliance. consumer health - Seizures.
  • MedlinePlus Health Information. consumer health - Epilepsy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15797352.001).
  • [ISSN] 1059-1311
  • [Journal-full-title] Seizure
  • [ISO-abbreviation] Seizure
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  •  go-up   go-down


95. Chatterjee S, Ghosh K, Raychoudhuri A, Chowdhury G, Bhattacharya MK, Mukhopadhyay AK, Ramamurthy T, Bhattacharya SK, Klose KE, Nandy RK: Incidence, virulence factors, and clonality among clinical strains of non-O1, non-O139 Vibrio cholerae isolates from hospitalized diarrheal patients in Kolkata, India. J Clin Microbiol; 2009 Apr;47(4):1087-95
MedlinePlus Health Information. consumer health - Cholera.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence, virulence factors, and clonality among clinical strains of non-O1, non-O139 Vibrio cholerae isolates from hospitalized diarrheal patients in Kolkata, India.
  • The incidence of Vibrio cholerae non-O1, non-O139 strains from hospitalized patients with acute diarrhea constituted 27.4% (n = 54) of the total 197 V. cholerae strains isolated from patients in Kolkata, India, in 2003.
  • Serotype analysis of the non-O1, non-O139 strains placed 42 strains into 19 serogroups, while 12 remained O nontypeable (ONT); the existing serotyping scheme involved antisera to 206 serogroups.
  • The non-O1, non-O139 strains were nontoxigenic except for an O36 strain (SC124), which regulated expression of cholera toxin as O1 classical strains did.
  • [MeSH-major] Bacterial Proteins / genetics. Cholera / epidemiology. Cholera / microbiology. Vibrio cholerae non-O1 / isolation & purification. Virulence Factors / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Animals. Child. Child, Preschool. DNA, Bacterial / chemistry. DNA, Bacterial / genetics. Diarrhea / epidemiology. Diarrhea / microbiology. Hospitalization. Humans. Incidence. India / epidemiology. Infant. Infant, Newborn. Mice. Middle Aged. Molecular Sequence Data. Sequence Analysis, DNA. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Microbiol. 2000 Nov;38(11):4145-51 [11060082.001]
  • [Cites] Infect Immun. 1979 Dec;26(3):1020-7 [118926.001]
  • [Cites] J Med Microbiol. 2001 Mar;50(3):268-76 [11232774.001]
  • [Cites] J Med Microbiol. 2001 Oct;50(10):879-88 [11599737.001]
  • [Cites] J Clin Microbiol. 2001 Nov;39(11):4086-92 [11682534.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1556-61 [11818571.001]
  • [Cites] Plasmid. 1981 Jul;6(1):112-8 [7025054.001]
  • [Cites] J Clin Microbiol. 1986 Mar;23(3):652-4 [3007571.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 May;84(9):2833-7 [2883655.001]
  • [Cites] J Exp Med. 1988 Oct 1;168(4):1487-92 [2902187.001]
  • [Cites] Jpn J Med Sci Biol. 1990 Dec;43(6):255 [2101148.001]
  • [Cites] Environ Microbiol. 2006 Mar;8(3):526-634 [16478458.001]
  • [Cites] J Med Microbiol. 2007 Jun;56(Pt 6):824-32 [17510270.001]
  • [Cites] Mol Microbiol. 1992 Feb;6(4):451-8 [1560773.001]
  • [Cites] Infect Immun. 1992 Nov;60(11):4848-55 [1398996.001]
  • [Cites] J Clin Microbiol. 1993 Jan;31(1):22-5 [7678018.001]
  • [Cites] Lancet. 1993 Jun 26;341(8861):1661 [8100020.001]
  • [Cites] J Infect. 1993 Jul;27(1):11-5 [8370939.001]
  • [Cites] J Med Microbiol. 1993 Oct;39(4):310-7 [8411093.001]
  • [Cites] Epidemiol Infect. 1995 Feb;114(1):65-70 [7867744.001]
  • [Cites] Clin Microbiol Rev. 1995 Jan;8(1):48-86 [7704895.001]
  • [Cites] J Med Microbiol. 1995 Apr;42(4):251-7 [7707332.001]
  • [Cites] J Med Microbiol. 1995 Sep;43(3):216-20 [7650730.001]
  • [Cites] J Clin Microbiol. 1995 Oct;33(10):2715-22 [8567912.001]
  • [Cites] Science. 1996 Jun 28;272(5270):1910-4 [8658163.001]
  • [Cites] Infect Immun. 1996 Aug;64(8):3101-8 [8757840.001]
  • [Cites] Indian J Med Res. 1996 Feb;103:71-3 [8714141.001]
  • [Cites] Microbiology. 1996 Aug;142 ( Pt 8):2165-74 [8760931.001]
  • [Cites] Infect Immun. 1997 Feb;65(2):801-5 [9009346.001]
  • [Cites] Mol Microbiol. 1997 Sep;25(6):1099-111 [9350866.001]
  • [Cites] Kansenshogaku Zasshi. 1997 Oct;71(10):1037-45 [9394556.001]
  • [Cites] J Clin Microbiol. 1998 Mar;36(3):756-63 [9508308.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3134-9 [9501228.001]
  • [Cites] FEMS Immunol Med Microbiol. 1998 Mar;20(3):201-7 [9566491.001]
  • [Cites] Mol Microbiol. 1998 May;28(3):501-20 [9632254.001]
  • [Cites] Microbiol Mol Biol Rev. 1998 Dec;62(4):1301-14 [9841673.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1071-6 [9927695.001]
  • [Cites] Epidemiol Infect. 1999 Apr;122(2):217-26 [10355785.001]
  • [Cites] FEMS Microbiol Lett. 1999 Oct 15;179(2):255-63 [10518724.001]
  • [Cites] FEMS Microbiol Lett. 1999 Oct 15;179(2):401-7 [10518743.001]
  • [Cites] J Clin Microbiol. 2004 Dec;42(12):5854-6 [15583324.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1702-7 [15653771.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3465-70 [15728357.001]
  • [Cites] Infect Immun. 2006 Feb;74(2):1141-7 [16428762.001]
  • [Cites] Mol Microbiol. 2002 Jan;43(1):119-34 [11849541.001]
  • [Cites] Indian J Med Res. 2001 Sep;114:77-82 [11873401.001]
  • [Cites] Infect Immun. 2002 Aug;70(8):4735-42 [12117994.001]
  • [Cites] Curr Opin Microbiol. 2003 Apr;6(2):186-90 [12732310.001]
  • [Cites] FEMS Microbiol Lett. 2004 Mar 12;232(1):23-30 [15019730.001]
  • [Cites] J Bacteriol. 2004 Aug;186(15):4864-74 [15262923.001]
  • [Cites] J Clin Microbiol. 2004 Oct;42(10):4657-71 [15472325.001]
  • [Cites] Am J Clin Pathol. 1966 Apr;45(4):493-6 [5325707.001]
  • [Cites] J Infect Dis. 1968 Feb;118(1):25-31 [5640984.001]
  • [Cites] Infect Immun. 1973 Dec;8(6):851-9 [4206342.001]
  • [Cites] J Assoc Physicians India. 2000 May;48(5):505-6 [11273144.001]
  • (PMID = 19158257.001).
  • [ISSN] 1098-660X
  • [Journal-full-title] Journal of clinical microbiology
  • [ISO-abbreviation] J. Clin. Microbiol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ EU689098/ EU689099/ EU689100/ EU689101/ EU689102
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / DNA, Bacterial; 0 / Virulence Factors
  • [Other-IDs] NLM/ PMC2668327
  •  go-up   go-down


96. Hayashi T, Hirano T, Shiobara T, Suguro T, Adachi M: [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol]. Rinsho Byori; 2006 Jun;54(6):569-75

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].
  • On the other hand, non-HDL-C has been proposed as an integrated CHD risk marker containing all atherogenic apo B-containing lipoproteins.
  • We examined which apo B or non-HDL-C is superior marker in reflecting sd-LDL particles.
  • LDL-C, non-HDL-C, and apo B were highly associated with each other(r=0.78 approximately 0.87), and all were associated with C, apo B, and TG in sd-LDL.
  • Mean LDL diameter was negatively associated with apo B but not with non-HDL-C.
  • These results suggest that apo B is superior to non-HDL-C in reflecting a potent atherogenic lipoprotein, sd-LDL, which may explain a potent predictive power of apo B for CHD.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Coronary Disease / blood. Dyslipidemias / blood. Female. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16872005.001).
  • [ISSN] 0047-1860
  • [Journal-full-title] Rinsho byori. The Japanese journal of clinical pathology
  • [ISO-abbreviation] Rinsho Byori
  • [Language] jpn
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Apolipoproteins B; 0 / Cholesterol, LDL; 0 / Lipoproteins, LDL
  •  go-up   go-down


97. Russell LJ, Akasaka T, Majid A, Sugimoto KJ, Loraine Karran E, Nagel I, Harder L, Claviez A, Gesk S, Moorman AV, Ross F, Mazzullo H, Strefford JC, Siebert R, Dyer MJ, Harrison CJ: t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood; 2008 Jan 01;111(1):387-91
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).
  • Translocations involving the immunoglobulin heavy chain locus (IGH@) at chromosome band 14q32 are common in mature B-cell neoplasms, but are rare in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).
  • [MeSH-major] Immunoglobulin Heavy Chains / genetics. Inhibitor of Differentiation Proteins / genetics. Leukemia, B-Cell / genetics. Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics. Translocation, Genetic
  • [MeSH-minor] Adolescent. Adult. Base Sequence. Child. Chromosomes, Human, Pair 14. Chromosomes, Human, Pair 6. Chromosomes, Human, Pair 9. Female. Gene Deletion. Genes, p16. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged. Molecular Sequence Data. PAX5 Transcription Factor / genetics. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17940204.001).
  • [ISSN] 0006-4971
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / MC/ U132670597
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ID4 protein, human; 0 / Immunoglobulin Heavy Chains; 0 / Inhibitor of Differentiation Proteins; 0 / PAX5 Transcription Factor; 0 / PAX5 protein, human
  •  go-up   go-down


98. Alfonzo M, Suárez J, Díaz A, Comegna M, Valenzuela P, Sánchez M, Hernández D, Hung A: [Altered expression of survival (CD127) and death (Fas) receptors in total, naïve and memory CD8 T lymphocytes from human immunodeficiency virus infected patients: possible implications for progression of infection]. Invest Clin; 2008 Jun;49(2):151-68
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Results indicate how the progression of VIH infection in non-treated patients is related to a decrease of CD8+ T cells in blood, characterized by failures in their proliferative capacity and apoptosis frequency, which is demonstrated by the altered expression of CD127 and CD95/Fas expression.
  • [MeSH-minor] Adult. Apoptosis. CD4 Lymphocyte Count. Cell Division. Cells, Cultured / metabolism. Disease Progression. Female. Gene Expression Regulation. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18717263.001).
  • [ISSN] 0535-5133
  • [Journal-full-title] Investigación clínica
  • [ISO-abbreviation] Invest Clin
  • [Language] spa
  • [Publication-type] Comparative Study; English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Venezuela
  • [Chemical-registry-number] 0 / Antigens, CD95; 0 / Interleukin-7 Receptor alpha Subunit
  •  go-up   go-down


99. Zadik Y, Burnstein S, Derazne E, Sandler V, Ianculovici C, Halperin T: Colonization of Candida: prevalence among tongue-pierced and non-pierced immunocompetent adults. Oral Dis; 2010 Mar;16(2):172-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colonization of Candida: prevalence among tongue-pierced and non-pierced immunocompetent adults.
  • SUBJECTS AND METHODS: Swabs samples were obtained from the anterior lingual mucosa of healthy young adults with tongue piercing (N = 115); 86 subjects with (non-intra-oral) facial piercing served as a comparison group.
  • No difference was found between current tongue ornament wearers (21.2%) and non-wearers (19.5%; P = 0.803).
  • [MeSH-minor] Adolescent. Adult. Alcohol Drinking. Colony Count, Microbial. Face / microbiology. Female. Humans. Immunocompetence / immunology. Male. Mouth Mucosa / microbiology. Oral Hygiene. Smoking. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19732353.001).
  • [ISSN] 1601-0825
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


100. Karube K, Suzumiya J, Okamoto M, Takeshita M, Maeda K, Sakaguchi M, Inada T, Tsushima H, Kikuchi M, Ohshima K: Adult T-cell lymphoma/leukemia with angioimmunoblastic T-cell lymphomalike features: Report of 11 cases. Am J Surg Pathol; 2007 Feb;31(2):216-23

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult T-cell lymphoma/leukemia with angioimmunoblastic T-cell lymphomalike features: Report of 11 cases.
  • In adult T-cell lymphoma/leukemia (ATLL), the neoplastic lymphoid cells are usually medium-sized to large, often with pronounced nuclear pleomorphism compatible with the diagnosis of diffuse pleomorphic peripheral T-cell lymphoma.
  • All patients were positive for antiadult T-cell leukemia/lymphoma-associated antigen, which is a specific antibody for human T-cell lymphotropic virus type-I.
  • [MeSH-major] Immunoblastic Lymphadenopathy / pathology. Leukemia-Lymphoma, Adult T-Cell / pathology. Lymphoma, T-Cell / pathology
  • [MeSH-minor] Adult. Aged. Antigens, CD / metabolism. Biomarkers, Tumor / metabolism. DNA, Viral / analysis. Female. HTLV-I Infections / virology. Humans. Male. Middle Aged. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17255766.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Biomarkers, Tumor; 0 / DNA, Viral
  •  go-up   go-down






Advertisement